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 E. coli O157 is an intestinal pathogen of man that causes bloody and non-bloody 
diarrhea as well as potentially fatal systemic sequelae.  It is causative of an emerging 
infectious disease first recognized in a foodborne disease outbreak in 1982.  Since that 
time, additional outbreaks and sporadic cases have focused a great deal of research 
attention upon this pathogen and the diseases it causes. 
 Areas of active research for E. coli O157 and its diseases include genomics, 
epidemiology, pre-harvest and post-harvest food safety, pathogenesis, diagnostics, 
vaccination, and treatment.   
 Two of the studies described herein are important to the improved understanding 
of pre-harvest food safety related to food contamination by E. coli O157.  In this regard, 
these studies demonstrate advances in reliably mimicking E. coli O157 colonization of 
adult cattle and also demonstrate a nutritional basis for its colonization.  Reliably 
modeling natural infection allows hypotheses concerning E. coli O157 cattle colonization 
to be tested.  As evidence, we demonstrate the testing of the hypothesis of a nutritional 
basis for colonization by utilizing a model that mimics natural colonization. 
 The final study described herein addresses the need for improved diagnostics by 
discovery-based investigations of the isolation of in vitro selected aptamers as 
recognition elements for E. coli O157.  Application of novel recognition elements in 
diagnostic platforms could result in improved diagnostic tools utilized in settings that 








Escherichia coli O157: 






 E. coli O157 is a significant pathogen that causes foodborne illnesses in man 
without causing significant disease in cattle, the primary reservoir.  This pathogen is the 
archetypal member of the enterohemorrhagic E. coli (EHEC) and is monitored and 
investigated closely as an emerging infectious disease pathogen.  Herein, the 




 E. coli O157 is a gram-negative, facultative anaerobic, enteric bacterium that is 
causative of significant human disease (67, 92, 105).  First associated with human disease 
in 1982 in a foodborne illness outbreak (112), it is classified as an emerging infectious 
disease pathogen (94) and as such, has warranted a high level of attention recently as its 
disease pathogenesis  and its epidemiology have become more fully understood. 
 E. coli is the most well-studied of all bacteria.  Most E. coli are commensals of 
mammalian intestinal tracts (34) and typically colonize the intestine of human infants 
within a few hours of birth (67).  However, a diversity of pathogenic E. coli strains have 
been characterized and are associated with illnesses ranging from diarrhea to urinary tract 
infections, meningitis, or septicemia (67).  The diarrheagenic E. coli are a group of 
organisms that, upon infection, cause diarrhea in the host.  The diarrheagenic E. coli are 
divided into a variety of pathotypes based upon their genotype and their mechanisms of 
pathogenesis.  These pathotypes provide clinical diagnosticians, medical personnel, and 
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researchers a categorization schema allowing better understanding of the epidemiology, 
pathogenesis, diagnostics, and treatment of these significant enteric illnesses (92). 
 The three most fully understood and characterized diarrheagenic E. coli 
pathotypes are: enterotoxigenic E. coli (ETEC), enteropathogenic E. coli (EPEC), and 
enterohemorrhagic E. coli (EHEC).  Other pathotypes include enteroinvasive E. coli 
(EIEC), enteroaggregative E. coli (EAggEC), diffusely adherent E. coli (DAEC), and the 
recently characterized adherent and invasive E. coli (AIEC) (25, 67). 
 Enterotoxigenic E. coli (ETEC) are those E. coli strains that produce one or both 
of the enterotoxins known as labile-toxin (LT) and stable toxin (ST) (79).  ETEC is 
largely a pathogen of developing countries, where it causes traveler’s diarrhea (67).  The 
labile-toxin (LT) is a classical AB5 subunit toxin consisting of five identical B subunits 
that bind host cell gangliosides and an A subunit that mediates the toxin’s ADP-ribosyl 
transferase activity.  This activity transfers an ADP-ribosyl moiety from NAD to a G 
protein which regulates adenylate cyclase.  The net result is persistent activation of 
adenylate cyclase, increased cAMP levels in affected cells, increased chloride secretion 
from activated crypt epithelial chloride channels, and inhibition of NaCl uptake by villus 
tip epithelium leading to an osmotic diarrhea (92).  The stable toxin (ST) is a small 
peptide of two types: STa associated with human disease and STb associated with animal 
disease.  STa binds the guanylate cyclase receptor on host cells and activates cGMP or 
cAMP-dependent kinases resulting in hypersecretion of ions.  STb can mediate ion 
hypersecretion by increasing cytosolic calcium concentrations or by stimulating the 
release of serotonin or prostaglandin E2 (67). 
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 Enteropathogenic E. coli (EPEC) and enterohemorrhagic E. coli (EHEC) are both 
members of the attaching and effacing E. coli (AEEC) pathotype, a less descriptive 
pathotype designation that has fallen into disuse.  EPEC and EHEC infection both result 
in an attaching and effacing histopathological lesion of enteric mucosa, the basis for their 
categorization in the AEEC pathotype (67).  This similarity is based in the genomics of 
each pathotype, but they are dissimilar in other key features.  These will be briefly 
summarized below, and a more comprehensive description of the pathogenesis and 
virulence of E. coli O157 will follow. 
 EPEC and EHEC both possess the locus of enterocyte effacement pathogenicity 
island, and encoded proteins from this island mediate attachment to host enterocytes 
similarly (34).  The locus of enterocyte effacement has a similar complement of genes in 
both pathotypes, and the principal effectors include intimin, Tir (translocated intimin 
receptor), and a variety of secreted proteins (Esp’s) (72).  The principal change in host 
cells is intimate attachment of bacteria accompanied by effacement of the microvillus 
border as well as cytoskeletal rearrangement manifested as cellular pedestals composed 
of polymerized actin beneath the attached bacterium (34). With respect to issues 
concerning evolutionary divergence, it is interesting to note the sequence divergence of 
Tir and intimin within EPEC and EHEC (31, 139).  Tir has been analyzed for functional 
interchangeability between EPEC and EHEC in knockout and complementation 
experiments.  For EPEC, formation of the pedestals is dependent upon tyrosine 
phosphorylation of Tir; the phenotype is not complemented by Tir from EHEC.  The 
reverse is not true as EHEC complemented with EPEC Tir was able to form pedestals 
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(31).  Additionally, EPEC Tir’s binding of host cell protein Nck is necessary to initiate 
actin polymerization, but is not required in EHEC (13).   
 In addition to differences in Tir and intimin between EPEC and EHEC, the type 
IV bundle-forming pilus is produced by EPEC, and not EHEC (45).  The bundle-forming 
pilus (Bfp) is an early attachment factor for EPEC (45) and is encoded upon an EAF 
(EPEC adherence factor) plasmid (93).  Conversely, Shiga toxins are produced by EHEC, 
and not EPEC (105).  Shiga toxins are encoded on lysogenic lamboid phages integrated 
into the chromosome (105). 
 
Virulence and Pathogenesis of E. coli O157 
 E. coli O157 infection in man results in asymptomatic infection to watery or 
bloody diarrhea (92).  In a small subset of infections, especially in the elderly and in 
children under five years of age, an occasionally fatal sequela known as hemolytic-
uremic syndrome (HUS) can develop.  HUS is clinically defined and recognized by a 
triad of clinical symptoms including microangiopathic anemia, thrombocytopenia, and 
uremia (47). 
 E. coli O157 possesses several virulence factors, including: Tir and intimin within 
the locus of enterocyte effacement; the large pO157 virulence plasmid; and 
lipopolysaccharide; but the key virulence factor is the Shiga toxin (67), also known as 
verocytotoxin (VT).  Greater than 200 serotypes of E. coli can produce Shiga toxins, and 
Shiga-positive and Shiga-negative strains exist in most serotypes (65).  Additionally, 
many of these serotypes do not possess the locus of enterocyte effacement and do not 
cause disease (67).  Because of this, additional nomenclature is utilized: STEC for Shiga-
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toxin producing E. coli and VTEC for verotoxin-producing E. coli – which are both 
synonymous terms for any E. coli strain that produces Shiga toxins.  The term EHEC is 
utilized to indicate the subset of E. coli strains that produce Shiga toxin and contain the 
locus of enterocyte effacement (67).  For example, STEC strains associated with piglet 
edema disease do not possess the locus of enterocyte effacement and are not classified as 
EHEC. 
 E. coli O157 causes characteristic intestinal histopathology known as attaching 
and effacing histopathology (a term coined by Moon (87)) that is accompanied by 
hemorrhage and edema in the lamina propria (52).  Attaching and effacing histopathology 
has been seen in animal and in vitro models including young calves (30), rabbits (102), 
lambs (132) intestinal explants (4), and cultured epithelium (76) infected with E. coli 
O157.  However, this histopathology has not been seen in clinical human samples, a 
feature likely explained by the temporal delay between disease onset with high numbers 
of organisms and late disease, when attaching and effacing lesions are likely to be absent 
(92). 
 Shiga toxins are classical AB5 toxins possessing five identical B subunits that 
mediate receptor binding and a catalytically active A subunit (105).  Shiga B subunits 
bind the host glycolipid receptor globotriaosylceramide (Gb3).  This receptor is variably 
expressed across host species and across anatomic loci (86).  In rabbits, Shiga toxin is 
thought to translocate via Gb3 receptors in the ileum, but in humans the pathway is not 
known (105).  Upon translocation and entry (126) into the bloodstream, the toxin targets 
tissues expressing the Gb3 receptor, which in humans includes the renal cortex and 
vasculature. Because the kidney is a principal site of lesion formation in HUS (47, 105), 
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this focus of receptor expression is important for analysis.  In a study of Shiga toxin 
binding to infant and adult human renal sections, it was shown that levels were highest in 
adult kidneys with most localization at the distal convoluted tubule.  Although pediatric 
kidney had lower levels of localization in the kidney, pediatric expression occurred in the 
distal tubule as well as the glomerulus, a finding that is consistent with the increased 
incidence of HUS in young children (80). 
 Upon receptor binding, Shiga toxin is internalized via coated pits and is 
retrotranslocated to the endoplasmic reticulum via the Golgi apparatus.  Here, the A 
subunit enters the cytosol and cleaves a single adenine residue from the 28S rRNA of the 
60S ribosomal subunit via its N-glycosidase activity.  This action terminates protein 
synthesis leading to the death of renal endothelium, renal tubular epithelium, and other 
loci where Gb3 expression is present (105). 
 The contribution of Shiga toxins to intestinal disease is variable and differs 
according to animal model.  Nataro’s review concludes that the “ability of EHEC to 
produce the A/E (attaching and effacing) lesions is probably sufficient to cause 
nonbloody diarrhea but that Stx is essential for the development of bloody diarrhea and 
hemorrhagic colitis.” (92)  The contribution of Shiga toxins to HUS is more defined.  
Upon bloodborne translocation to the kidney, Shiga toxin damages renal endothelium and 
occludes the glomerular microvasculature.  This is mediated through direct effects and 
through induction of cytokine and inflammatory pathways (3).   
 Although the linkage between HUS and the Shiga toxin is established (105), an E. 
coli O157 Shiga toxin-negative strain associated with a case of pediatric HUS has been 
reported (115).  Schmidt and colleagues speculate that E. coli O157 factors other than 
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Shiga toxin may be capable of causing HUS (115).  Consistent with that speculation is 
the observation that two other Shiga toxin-negative bacteria, Streptococcus pneumoniae 
(2) and Neisseria meningitidis (73), have been associated with cases of HUS.   
 The locus of enterocyte effacement (LEE) encodes a type III secretion system and 
effector proteins known as intimin, Tir (translocated intimin receptor), and Esps.  
Although differences of the LEE between EPEC and EHEC have already been 
highlighted, an additional difference is that the effects of LEE gene products of EPEC are 
seen in the small intestine, and in EHEC, in the large intestine (67).   
 The pO157 plasmid (12) encodes two additional virulence factors, whose 
importance have yet to be established.  ToxB, a potential adhesin, is homologous to the 
EPEC LifA protein (75) and the non-O157 EHEC Efa-1 adhesin (96).  Enterohemolysin 
is a second candidate virulence factor on the pO157 plasmid (114).   
 Human infection with E. coli O157 is usually by the fecal-oral route and the 
successful infectious dose is notoriously low, estimated from 1 to 100  to 100 to 200 
microorganisms (92, 105).  Upon ingestion, E. coli O157 can successfully traverse the 
acidic environment of the stomach because E. coli O157 has a complement of acid-
resistance mechanisms (141).  The human disease usually begins 24 hours after ingestion 
of contaminated food or water with abdominal cramping followed shortly by watery 
diarrhea.  Bloody diarrhea, if it occurs, then follows 24-72 hours later.  Therapeutics in 
man are generally supportive in nature (92), but treatment with antibiotics is controversial 
(62, 105) and one study recommended that antibiotics of choice should disrupt protein 
synthesis and not inhibit DNA repair (62). 
10 
 
 In concluding this section on virulence and pathogenesis, inclusion of published 
and annotated genomes is appropriate as it provides a perspective on evolutionary 
relationships and highlights candidate genes for future investigations of pathogenesis.  E. 
coli O157 has been sequenced twice, with both sequenced isolates originating from 
human outbreaks (57, 106).  In comparing the two published E. coli O157 genomes to E. 
coli K12 MG1655, E. coli O157 and E. coli K 12 MG1655 share a largely collinear 4.1 
Mb backbone (57), and the total genomic size of E. coli O157 is 5.5 Mb (57, 106).  Perna, 
et al, predicted 1387 genes were novel to E. coli O157 (106) while Hayashi, et al, 
predicted 1632 novel E. coli O157 genes (57), the differences likely originating from 
differing annotation algorithms.  Additionally, E. coli O157 EDL 933 and E. coli K12 
MG1655 were compared to the genome of the closely related Shigella flexneri 2a, and it 
was found that the three bacteria share a 3.9 Mb, largely collinear, chromosomal 
backbone, and the key difference possessed by S. flexneri 2a was the plasmid pCP301, 
comprised of genes conferring the invasive phenotype upon it (64).  As this genome 
information becomes more reliably annotated and as investigators utilize the information 
to confirm functional relationships, a more thorough understanding of pathogenesis and 
improved targets for epidemiologic surveillance will correlate with improved human 
health. 
 
E. coli O157: Reservoir and Colonization Models 
 The primary and most frequently identified reservoir of E. coli O157 is the bovine 
gastrointestinal tract (95).  Other animal reservoirs of E. coli O157 that have been 
identified include sheep, goats, pigs, horses, dogs, turkeys, wild birds, whitetail deer, 
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rabbits,  rodents, and flies (1, 8, 9, 35, 44, 56, 60, 77, 91, 97, 110, 133).   To date, a 
comprehensive investigation into sites of recovery of E. coli O157 from slaughtered 
cattle has not been performed.  However, in an experimental colonization of young adult 
cattle, the predominant site of E. coli O157 colonization was the lower gastrointestinal 
tract with lesser magnitude recovery from the rumen and duodenum (48).  The tropism 
for the lower intestine was further confirmed and restricted to the lymphoid follicle-rich 
mucosa of the terminal rectum (95).  Additionally, Pohlenz demonstrated O157 
colonization of the squamous mucosa of the recto-anal junction (107).  Other important 
loci of O157 isolation in cattle include the oral cavity and hide surfaces.  One prevalence 
distribution study showed that 74.8% of feedlot cattle were positive for E. coli O157 in 
the oral cavity and that 41.0 to 73.4% of these cattle were O157-positive at various places 
on the hide (70). 
 Quantitative assessment of shedding of E. coli O157 by cattle is important 
because of its impact on environmental contamination and its impact upon the bases for 
transmission and intermittent shedding.  Investigations into numbers of E. coli O157 shed 
by cattle have yielded important, yet variable, insights.  In one study, at the third day 
post-inoculation, adult cattle shed an average of 1.0 X 105 cfu/g feces, whereas similarly 
colonized young calves shed 6.3 X 106 cfu/g feces (23).  This demonstrated the 
importance of O157-infected calves with respect to environmental contamination.  In a 
field prevalence survey of dairy herds, shedding was documented to vary from 102 to 106 
cfu/g feces (143).   
 Cattle have been intentionally colonized by E. coli O157 via a variety of 
procedures.  Oral colonizations via dose syringe or stomach tube (22, 23, 26-30, 49, 61, 
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95, 117) , ruminal colonizations via rumen cannulas (48, 128), and rectal colonizations 
(117) have been documented.  All methods have been utilized in adult cattle and each 
method has achieved similar colonization levels.  With respect to ease of administration 
and persistence of colonization, the rectal administration model was superior to oral 
colonization in a direct comparison (117).  Additionally, high infectious doses (1010 
cfu/animal) consistently outperform lower infectious doses (107 or lower) with respect to 
higher magnitude and longer persistence of colonization in many studies (23, 117). 
 While cattle are the primary reservoir of E. coli O157, they do not exhibit 
significant disease as adults (23) and only transient diarrhea as young calves (10, 23, 30).  
One of the key determinants of this immunotolerance may be the species differences in 
Shiga-toxin receptor expression.  In man, the Shiga-toxin receptor, globotriaosylceramide 
(Gb3) is expressed in renal glomeruli, renal tubules, brain, and vasculature (105).  Cattle 
lack vascular and intestinal epithelial receptors for Shiga toxin, but do express the Shiga-
toxin receptor in renal tubules and in the brain (108).  Although cattle appear resistant to 
the effects of Shiga toxin due to the lack of vascular receptors, they do exhibit attaching 
and effacing histopathology during colonization of calves (30), but this was not exhibited 
in adult cattle (23) until Naylor’s recent report demonstrated the pathology in a yearling 
(95).   Further, in a study of large intestinal explants from adult cattle, it was 
demonstrated that O157 exhibits attaching and effacing histopathology in adult tissues 
(4).  The best explanation for the difficulty of demonstrating attaching and effacing 
histopathology in adult cattle is the fact that 106 cfu/g of feces is a recognized threshold 
for recognition of adherent bacteria in histopathologic sections of intestine (6), and adult 
cattle typically do not maintain this level of colonization (23).   
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 Some colonization models have been specifically directed at investigating 
attachment strategies of E. coli O157.  Intimin was shown to be important in the 
colonization and enteropathogenicity in young calves by colonizing with intimin-positive 
and intimin-negative strains of E. coli O157 (30).  Further, it was similarly shown to be 
important in young adult cattle and sheep (22).  Although demonstrated only in sheep and 
pigs, long polar fimbriae knockout mutants of E. coli O157 also demonstrated a defect in 
colonization (66).  Lipopolysaccharide O-antigen chains were investigated in an in vitro 
model of attachment and were found not to be required (21).  As a whole, this summary 
of published results is reasonably consistent with a comprehensive determination of the 
genes essential for the colonization of the bovine intestinal tract (37) by use of signature-
tagged mutagenesis.  In that study by Dziva and colleagues (37), several genes involved 
in the type III secretion system were implicated; this is consistent with the colonization 
defects seen with absence of intimin, a type III secretion system effector protein.  A 
fimbrial usher protein was implicated in Dziva’s study; its association with the long polar 
fimbriae is not known.  Finally, this study implicated at least five genes in 
lipopolysaccharide biosynthesis, and this appears to be at odds with the study on O-
antigen contributions to adhesion (21). 
 Other models or field investigations have focused upon environmental influences, 
diet, and other factors.  Intermittency of shedding has been documented by many (23, 
109, 117).  The impact of age and colonization bolus level has consistently shown that 
younger cattle are more reproducibly colonized with persistence and that high infectious 
doses provide more reliable colonizations (23, 29, 117).  Dietary influences have been 
investigated, with more variability to the results.  In a more comprehensive investigation 
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of dietary influence upon success of acid-resistant coliform colonization, Diez-Gonzalez 
(32) demonstrated higher colonizations with cattle on a grain diet.  However, in a specific 
investigation of E. coli O157’s acid resistance, Hovde (61) demonstrated the reverse to be 
true.  A study authored by Van Baale (128) was in close agreement with Hovde’s results.  
Seasonality influences have also been investigated in sheep and cattle, with 
generalization across studies inhibited by marked differences in design and sampling 
times.  One bovine study analyzed culture swabs post-slaughter and demonstrated the 
highest culture positive incidence in the summer (18).  In dairy cattle, peak culture 
positive incidence was seen in the spring and in November (85).   
 An E. coli O157 colonization model developed in mice (131) demonstrated stable 
and persistent colonizations with fecal shedding of 107-8 cfu/g feces of the input E. coli 
O157.  In addition to increased understanding of colonization, this murine model also 
assessed pathogenicity to some extent because the mice were not resistant to the effects 
of virulence factors.  Young chickens have also been experimentally colonized.  
According to the authors, the benefit of this model was in the study of attaching and 
effacing lesions that were induced in the chickens (121).  Rabbits have also served as a 
colonization model (102).  Finally, although not directed at the problem of intestinal 
colonization, animal models of Shiga-toxin mediated disease have been developed in 
baboons (125) and mice (69).   
 Generalizing the results of these diverse studies is difficult.  However, four things 
are clear: 1) the shedding of E. coli O157 by cattle is intermittent, 2) calves are 
consistently higher shedders than adults and are important only from an environmental 
contamination standpoint, 3) colonization success is impacted by multiple factors, and 4) 
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determination of environmental impacts such as diet and season is difficult and suffers 
from competing and uncontrolled variables. 
 
Epidemiology of E. coli O157 Infection 
 Enterohemorrhagic E. coli O157 is found worldwide and has been reported in all 
continents except Antarctica (38, 74).  Emergence of this pathogen has been extensively 
analyzed using evolutionary genetics techniques (134).  It is thought that E. coli O157 
arose from a locus of enterocyte effacement (LEE) and Stx2-expressing E. coli O55 
progenitor via the stepwise acquisition of the O157 O-antigen rfb-gnd loci, loss of 
sorbitol fermentation, and loss of β-glucuronidase activity due to disruption of the uidA 
gene (39, 123, 135). Archetypal E. coli O157 is described as non-sorbitol fermenting and 
β-glucuronidase negative and is the most commonly isolated E. coli O157 strain in the 
U.S., U.K., Canada, and Japan (74).  Based upon phylogenetic analyses, other subclones 
of E. coli O157 have diverged at various points of the proposed evolutionary pathway 
(39) and successfully populated geographically restricted areas (74).  Of note, significant 
numbers of non-motile, sorbitol positive, β-glucuronidase-positive E. coli O157 are 
isolated in Europe (39) and non-motile, sorbitol-negative, β-glucuronidase-negative E. 
coli O157 are seen in Australia (113).   
 E. coli O157 was first associated with human disease in the U.S. in 1982 (112).  
Since that time, numerous outbreaks have been documented.  Perhaps the most notorious 
outbreak occurred in 1993 in Washington where consumption of undercooked hamburger 
at a national fast-food chain sickened over 500 people and killed four children (5).  
Although large outbreaks dominate news headlines, it is estimated that the sporadic E. 
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coli O157 infections represent the major health burden associated with this pathogen 
(92).  In the United States, it is estimated that E. coli O157 causes over 73,000 foodborne 
illness cases annually and that non-O157 STEC cause up to 36,740 more.  It was further 
estimated that E. coli O157 causes 60 deaths per year in the U.S. (84).   
 Reports of infections with EHEC appear to follow a geographic trend with 
infection more common in the northern versus the southern United States and also more 
common in western than eastern Canada (92).  Seasonality is also important with most 
sporadic cases documented in the summer (92).   
 Although most sporadic cases and outbreaks of hemorrhagic colitis are caused by 
E. coli O157 (92), incidence of disease due to other serotypes is rising (65).  The most 
common serotypes other than O157 implicated in human disease are O26, O103, O111, 
and O113 (53).  In fact, greater than 200 serotypes can express Shiga toxin, but Shiga-
positive and Shiga-negative strains are seen in most of these serotypes (65).  Such non-
O157 serotypes represent a diagnostic dilemma, as most of them do ferment sorbitol, 
making selective media such as sorbitol-MacConkey (vide infra) largely useless.  Even 
usage of Shiga toxin genetic markers is unreliable as Shiga toxin expression is not 
thought to solely confer full virulence upon EHEC (65).   
 The most important reservoir of E. coli O157 is the bovine intestinal tract (92, 95) 
and the fecal-oral route is the primary mode of infection in humans.  The infectious dose 
for E. coli O157 infection has been estimated to be as low as 1 to 100 or 100 to 200 
organisms (92, 105).   Contaminated foods of bovine origin, in particular ground beef, are 
an important cause of human infection (53).  In large packing houses, the preparation of 
ground beef involves the grinding of beef parts from thousands of cattle from different 
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farms.  Beef patties are then formed from this mixture and widely distributed 
geographically.  Therefore, E. coli O157 organisms from one infected animal can 
contaminate entire batches of ground beef (92).  The economic costs to the beef packing 
industry from a ground beef recall are staggering and can negatively impact the 
reputation of meat packers (83). 
 Numerous other food vehicles have been implicated in the transmission of EHEC.  
These include mayonnaise (51), radish sprouts (122), alfalfa sprouts (15), lettuce (88), 
sausage (90), salami (14), apple cider (7), and milk (89).  With the exception of milk, 
infection with these vehicles is thought to have occurred via water contaminated by cattle 
feces followed by consumption of these uncooked products (89, 92).  Contamination of 
milk is documented in bulk tank (raw) milk samples (89) and presumptively implicates 
direct fecal contamination at the time of milking. 
 Waterborne sources of E. coli O157 are also significant to the understanding the 
epidemiology of O157.  Because of its low infectious dose (92, 105), low level 
contamination of water could result in sporadic cases or outbreaks.  Recreational lakes, 
municipal water supplies, and well water have been documented in waterborne E. coli 
O157 cases (17).   
 The epidemiology of E. coli O157 infection also includes some less common or 
less considered sources.  Petting zoos have been documented to possess animals shedding 
E. coli O157 (59) and have been linked to human infections (59).  Outbreaks have 
occurred at child day care centers (99, 116), and person-to-person spread was the 
suggested means of transmission (99).  Additionally, an outbreak of E. coli O157 at a 
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county fair was epidemiologically concluded to originate from a contaminated building 
(129). 
 Finally, in addressing the epidemiology of E. coli O157, one can not ignore the 
potential of intentional usage of E. coli O157 as a biowarfare/bioterrorism agent.  
Although E. coli O157 has never been intentionally released, its low infectious dose and 
ease of environmental availability, coupled with its potential for morbidity or mortality, 
make it a candidate bioterrorism tool. The Centers for Disease Control have placed E. 
coli O157 as a category B bioterrorism agent (www.bt.cdc.gov/agent/agentlist-
category.asp#b), and this placement has resulted in increased resources for surveillance 
and research in the recent past. 
 
Diagnostics for E. coli O157 
 Detection of E. coli O157 in laboratory and field settings is a critical priority for 
E. coli O157 research and many exciting advances have been seen.  Prompt laboratory 
diagnosis can translate into more efficient outbreak intervention and improved patient 
care (92).   For example, the efficient diagnosis of initial cases in the 1993 Washington 
outbreak resulted in the recall of significant quantities of ground beef and prevented an 
estimated 800 additional primary infections (5).   
 Although several molecular-based diagnostic tests will be discussed in this 
section, the mainstay in clinical microbiology laboratories for the diagnosis of E. coli 
O157 continues to be routine culture of stool specimens.  CDC recommendations provide 
for routine culture of bloody diarrhea specimens with the SMAC media (16).  SMAC 
(Sorbitol-MacConkey) media is a selective media for the presumptive diagnosis of E. coli 
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O157 (81).  This media preparation takes advantage of the fact that ≥ 80% of E. coli are 
sorbitol fermenters (50), whereas E. coli O157 is known to ferment sorbitol slowly or not 
at all (101).  Colonies not fermenting sorbitol (presumptive E. coli O157) appear 
colorless on this medium (81).  However, this test lacks sensitivity as there is no known 
direct genetic linkage coupling Shiga toxin production and the inability to ferment 
sorbitol (92).  Also, sorbitol-fermenting E. coli O157 strains have been documented (54, 
74), and these isolates would be incorrectly diagnosed on SMAC media. 
 Modification of SMAC media to improve selectivity has been accomplished.  A 
common modification is the inclusion of cefixime and/or tellurite (potassium salt) to 
yield media known as C-SMAC, T-SMAC, or CT-SMAC (41, 92, 142).  Cefixime is a 
cephalosporin antibiotic advantageous to selectivity as it is more inhibitory to Proteus sp. 
than E. coli organisms (19).  Potassium tellurite is advantageous for selection as most E. 
coli O157 strains possess one or multiple copies of a tellurite resistance genetic island 
(124).  Another alternative to improve selectivity is to use the fluorogenic substrate 4-
methylumbelliferyl-B-D-glucuronide (MUG) incorporated into agar media.  Most strains 
of E. coli O157 and other enterohemorrhagic strains do not produce β-glucuronidase and 
cannot cleave MUG.  Most other E. coli do produce the enzyme, cleave the MUG 
substrate, and are fluorescent with 366nm UV light (50, 127). 
 An extensive body of literature has been published on utilization of genetic 
sequences for detection. These methods usually utilize the polymerase chain reaction and 
are highly sensitive and specific (92).  Because of their importance in pathogenesis, 
detection of one or both Shiga toxin genes (stx1 and stx2) has received much focus.  An 
early technique utilized a single degenerate primer pair to amplify both stx1 and stx2 
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genes (68), but now two primer sets are usually utilized and analyzed in tandem (92).  
Detection of O-antigen biosynthesis genes specific to E. coli O157 is utilized with 
success.  Study authors advocated utilizing PCR coupled with primary enrichment 
protocols to rapidly and specifically identify E. coli O157 (82).  Genes composing the 
locus of enterocyte effacement (LEE; eae genes) are additional attractive genetic 
amplification targets.  Here, detection is of the intimin gene product that, problematically, 
is common to EHEC and EPEC.  However, the 3’ end of the eae  is highly divergent 
among EHEC and EPEC strains (139), thereby allowing eae PCR primers specific for E. 
coli O157 to be designed and used to detect EHEC specifically (43).  Finally, genetic 
content of the large virulence plasmid is unique and restricted to E. coli O157 and other 
EHEC (92).  Specific primers and a PCR protocol were published to take advantage of 
this diagnostically-specific genetic restriction (40).   
 Although much of the PCR-based diagnostic testing is directed toward rapid 
human diagnostics, the technique is utilized in pre-harvest and post-harvest food safety 
surveillance.  PCR-based testing has been specifically adapted to bovine E. coli O157 
shedding surveillance (100) and to monitor for contamination of ground beef (42).   
 Many immunoassays are currently widely available for the detection of E. coli 
O157.  Most developed assays are directed at the detection of H antigens, O antigens, or 
Shiga toxins (92) and the latter two are discussed here.   
 O antigen detection for EHEC in immunoassay format is almost exclusively 
restricted to detection of O157.  This is a limitation because such testing can not detect 
representatives of the numerous, presumptively minor, other EHEC serotypes.  E. coli 
O157 antisera have been incorporated into ELISA kits, latex agglutination kits, and other 
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kits (92).  ELISA testing is utilized to directly detect O157 antigen in stool samples.  In 
one study, the ELISA kit utilized was more sensitive (91.2% vs.82.4%) than and 
similarly specific to SMAC plating coupled to immunofluorescence microscopy (104).  
Latex agglutination kits for confirmation of E. coli O157 are available from numerous 
suppliers, and three of them were evaluated in one study.  In this study, 159 strains of E. 
coli were analyzed and sensitivity and specificity were both 100% when compared to 
internal reference sera (119).  Any immunoassay developed with monoclonal antibodies 
to the O157 O antigen could suffer from cross-reactivity issues because E. coli O157 has 
identical or cross-reactive epitopes with E. coli O44 and O55 (118), Brucella abortus, 
Salmonella O30 strains, (33) Yersinia enterocolitica, Citrobacter freundii, Citrobacter 
sedlakii (130), Escherichia hermannii (111), and some non-O1 strains of Vibrio cholera 
(137). 
 Shiga toxin immunoassays are available to detect either Shiga toxin-1 or Shiga 
toxin-2.  Two commercially available tests evaluated in the literature are the Premier 
EHEC Test (Meridian Diagnostics) and the Duopath Verotoxin Test (Merck, Germany) 
(71, 103).  The Premier EHEC test is an ELISA format and performed well in one study 
comparing sensitivity and specificity to SMAC agar (71).  The Duopath test is also in 
ELISA format, and when compared to Premier EHEC as a gold standard, it exhibited 
100% specificity and sensitivity (103). 
 Immunomagnetic separation is a technique based upon commercially available 
paramagnetic particles (Dynal) which are derivatized with O157 monoclonal antibodies.  
Immunomagnetic separation with these particles has been successfully used to detect E. 
coli O157 in food (136, 138), water (138), and cattle feces (20).  In the detection of E. 
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coli O157 from cattle feces, Chapman, et al showed an approximately 100-fold increase 
in sensitivity over conventional culture methods (20).  It has also been shown to be highly 
sensitive in the detection of E. coli O157 in human feces (24).   
 As an alternative to antibody-based techniques, aptamers have been proposed to 
be developed and utilized in diagnostic testing for infectious agents (63), including E. 
coli O157.  Aptamers are DNA or RNA oligonucleotides that bind a target of interest on 
a physicochemical and electrostatic basis (58), in contrast to traditional usage of 
oligonucleotides as hybridization probes.  Here, in addition to a genotype (which is only 
meaningful to the accurate reproduction of the probe), the aptamer possesses a phenotype 
in its exhibition of affinity and selectivity for targets.  An aptamer selected to bind 
thrombin is perhaps the most successful and certainly most-studied in this emerging class 
of biomolecules (55).  Aptamers are selected from a complex, synthetic, oligonucleotide 
pool by an iterative process known as SELEX (systematic evolution of ligands by 
exponential enrichment) (46).  Each iteration (divided into “rounds”) results in affinity 
partitioning of winning ligands, which are then amplified via PCR and subjected to 
subsequent rounds.  To date, little has been published in the area of aptamer selection for 
bacterial targets except for the preliminary reports on aptamers that bound the anthrax 
toxin (11) and E. coli O111 (36).  However, if aptamer selection for bacterial targets is 
increasingly successful, their binding properties and other advantages will make them a 
useful alternative to antibodies in the future. 
 Other testing modalities not addressed include serology, which is not frequently 
used to diagnose infection of diarrheagenic E. coli strains other than EHEC.  Serology 
would suffer from the potential cross-reactivity of O antigen epitopes described above.  
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Still others include quantum dots coupled to immunomagnetic separation (120), time-
resolved fluorescence(140), fluorescence polarization (98), flow cytometry (78), and 
others.    
 
Conclusions 
 Although E. coli O157 is conventionally regarded as an emerging infectious 
disease agent, it is perhaps more appropriately considered to be an established infectious 
disease as the pathogen is routinely recognized in surveillance studies, is routinely 
screened for in human fecal analyses, and is the subject of comprehensive research 
endeavors.  Areas of active investigation in the near future will focus on interventional 
strategies in cattle to address pre-harvest food safety and non-antimicrobial strategies to 
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Streptomycin-treated Adult Cattle 





 The gram-negative bacterium Escherichia coli O157 causes bloody diarrhea and 
potentially fatal sequelae in man.  Cattle, the recognized primary reservoir, are resistant 
to the disease, but shed the pathogen in their feces which contaminate food products.  
Modeling the colonization of cattle with E. coli O157 is important to understand the host-
pathogen relationship, but many current approaches are only moderately reproducible, 
especially in adult cattle, from which bovine-derived food originates.  Therefore, a highly 
reproducible E. coli O157 colonization model effective in adult cattle was developed in 
this study.   Five yearling cattle were surgically cannulated in the duodenum, were treated 
daily with streptomycin via the duodenal cannula prior to and during experimental 
colonizations, and were colonized with 1010 cfu/animal of a streptomycin-resistant E. coli 
O157 via the duodenal cannula.  Colonization of rectal mucus and shedding in feces was 
monitored.  Streptomycin treatment benefitted the experimental colonization when 
compared to untreated controls during initiation (days 0-6) and early maintenance (days 
7-12) of colonization. Chemotherapeutic elimination of the colonizing strain followed by 
five repeated colonizations in the same animals was successful.  Culture positivity at 7 
days and 12 days was 100% and 84%, respectively, across all animals and trials.  
Animals were euthanized following the final colonization trial and quantitative 
localization of E. coli O157 was assessed temporally, with highest magnitude recovery 
occurring within terminal rectal mucus.  The described model is highly reproducible and 
is novel with respect to streptomycin treatment, usage of duodenal cannulas, and repeated 





 The gram-negative bacterium Escherichia coli O157 is an intestinal pathogen of 
man that causes hemorrhagic colitis and the occasionally fatal sequela known as 
hemolytic-uremic syndrome (21, 25).  Since 1982, when E. coli O157 was first associated 
with human disease following consumption of undercooked hamburger (29), the 
epidemiological link to food contamination, especially ground beef, has become 
established.  Contamination of ground beef and other food products, including leafy 
vegetables, processed meats, and milk, usually occurs via exposure to bovine feces 
(reviewed in (21)).  Indeed, the bovine intestinal tract is recognized as the primary 
reservoir of this pathogen, and yet, a comprehensive understanding of this host-pathogen 
interaction is still lacking.  Prior studies demonstrated variability with respect to 
occurrence, magnitude, and duration of E. coli O157 shedding by cattle in field and 
experimental situations.  Because such variability suggests that unknown host and/or 
environmental factors are at play, modeling E. coli O157 colonization in cattle is valuable 
to the improved understanding of colonization and in the evaluation of pre-harvest food 
safety interventional strategies. 
 Cattle are recognized as the primary reservoir of E. coli O157.  In the natural 
setting, factors impacting initial colonization of the naïve animal are unknown, but 
horizontal transmission is presumed and has been observed experimentally (10, 30).  
Sources implicated in potential inter-animal transmission include feces (10, 30), as well 
as water sources (10), hides, and the oral cavity (19).  Upon infection, age-related 
differences in pathogenicity are observed experimentally.  Neonatal calves (≤ 3 weeks) 
exhibit diarrhea and attaching/effacing histopathology that is most severe in the youngest 
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(6).  E. coli O157 pathogenicity is usually not observed in adult cattle (4, 6, 14, 30), but 
conflicting studies report the occurrence (7) or the absence (4) of pathogenicity of E. coli 
O157 following experimental colonization in young calves.  Establishment of 
experimental colonizations routinely requires inocula >107 cfu/animal (4), and many 
studies utilize ≥ 1010 cfu/animal to colonize cattle (4, 14, 30).  Higher colonization doses 
result in more consistent and persistent colonizations (30).  One group has speculated 
that, if experimental shedding data mimics the field observations, then heavy fecal 
contamination (≥ 10g) during high shedding periods is required for propagation of 
colonization within a herd (4).  Another group has hypothesized that, among E. coli 
O157-positive herds, a small number of “supershedders” enhance transmission within a 
herd (23). 
 Prevalence of E. coli O157 colonization within herds and individual animals has 
been extensively studied.  Within herds, E. coli O157 is widespread in dairy and beef 
operations (27).  Recent herd studies have reported a point-in-time prevalence ranging 
from 63% (5) to 100% (31).  Individual animal fecal prevalence in recent studies has 
ranged from 7% in a range calf survey (20) to 28% in a feedlot survey (9).  Yet, when 
hides and the oral cavity were sampled in addition to feces in a feedlot survey, prevalence 
increased to 96%, indicating that epidemiologic surveys in which only feces were 
sampled may have underestimated prevalence (19).  Other factors under investigation that 
impact prevalence include seasonality, with summer months being the recognized period 
with higher shedding (reviewed in (27)), and diet, with hay (16, 35) or grain (8) feeding 
favoring the colonization of E. coli O157 or generic, acid-resistant E. coli, respectively.  
Therefore, E. coli O157 shedding in cattle appears to be intermittent within a small 
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proportion of cattle within a herd, and factors impacting recrudescence of infection are 
not well understood.   
 Contaminated ground beef is recognized as the primary vehicle for E. coli O157 
infection in man (21).  In the U.S., per capita retail beef consumption in 2002 was 67.5 
pounds (34), a significant portion of which is ground beef originating from adult cattle. 
Between January and November 2004, greater than 30 million adult cattle were 
slaughtered in the U.S., while 768,000 (39-fold fewer) calves were slaughtered. (22) 
Because adult cattle represent the large majority of cattle slaughtered and most ground 
beef is derived from adult cattle, adult cattle are likely the primary source of 
contaminated ground beef.  Further, both beef and dairy cattle spend the majority of their 
lifespan as post-weaning adults instead of the neonatal or calfhood stage.  Therefore, 
special attention to modeling adult colonization by E. coli O157 is favored over modeling 
colonization in young calves. 
 Young calves and adult cattle have been successfully utilized in E. coli O157 
colonization models; however, key differences exist.  In a study in which both young 
calves and adults were colonized and assessed by fecal shedding, the adult colonizations 
were more short-lived and of lower magnitude when compared to the young calves (4).  
Low-level, short duration shedding has also been observed by others colonizing adult 
cattle (14, 30) and is also consistent with what is seen in the field (38).  The reasons for 
differing shedding patterns between adults and young calves are thought to be due to diet, 
age-related differences in rumen function, or an immune response.  However, a study of 
serological responses of cattle to E. coli O157 cast some doubt on the impact of the 
immune response upon E. coli O157 carriage in cattle.  In that study, there was no 
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correlation with the serological titer and elimination of the pathogen nor with protection 
from re-infection (18). 
 The primary objective of this study, the development of a colonization model in 
adult cattle to assess lower gastrointestinal factors influencing initiation and persistence 
of E. coli O157 colonization, was framed by several conceptual issues.  First, 
establishment of such colonization was explored and proposed in the context of Freter’s 
nutrient-niche hypothesis.  Next, persistence of the colonization and consistency of 
results were identified as significant problems.  Finally, factors impacting the cost of 
experimentation with adult cattle were deemed significant. 
 The large intestinal microflora is composed of hundreds of bacterial species, the 
majority of which are anaerobic.  This microflora is characterized by stable coexistence, 
with each population controlled by competition for limiting nutrients.  By implication, 
this microflora is resistant to “invading” species, unless the microflora is perturbed by an 
exogenous factor or the “invader” can more successfully compete for a given nutrient 
(11).  This, the essence of Freter’s nutrient-niche hypothesis, has not previously been 
addressed in established bovine E. coli O157 colonization models.  However, evidence 
supporting the hypothesis was demonstrated with a murine E. coli O157 colonization 
model.  In this model, mice were colonized with streptomycin-resistant E. coli O157 
strains and were treated continuously with oral streptomycin (36).  Streptomycin, an 
aminoglycoside antibiotic with poor oral absorption, is satisfactory for the treatment of 
susceptible, gram-negative enteric flora (17).  In the murine model, streptomycin 
treatment effected a perturbation of the native microflora by decreasing the facultative 
anaerobic bacteria from 108 cfu/g feces to 102 cfu/g feces, allowing the “invading” E. coli 
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O157 strains an opportunity to occupy a niche (36).  On this basis, we proposed a similar 
strategy of streptomycin treatment in the development of the model described herein. 
However, streptomycin could adversely affect rumen microflora if administered per os.  
The rumen microflora is composed of anaerobic and facultative anaerobic flora (as well 
as protozoa), and complex and interacting factors of this polymicrobial community 
control normal digestive and fermentation processes (13).  To the extent streptomycin 
would affect rumen microflora and function, adverse clinical side effects such as 
indigestion and anorexia (13) could affect the study.  Therefore, administration of 
streptomycin via a surgically-placed duodenal cannula as an alternative to oral 
administration was investigated.   
 Duodenal cannulas permit diversified approaches to placement of analytes and/or 
procurement of samples based upon a physical segregation of the complex and 
voluminous ruminant gastrointestinal tract.  Such cannulas are routinely placed and stably 
maintained for up to two years (15).  A duodenal cannula has been used in E. coli O157 
bovine colonizations, but in that study, it was used only for sampling (14).  The 
employment of a duodenal cannula in a streptomycin-treated adult cattle model could 
provide two key advantages.  First, it could provide a means for post-gastric 
administration of streptomycin, and second, it could provide the mode of administration 
of the experimental bacterial bolus.  The possibility of streptomycin side effects would be 
minimized or eliminated because normal ruminant digestive processes limit duodenal-
abomasal and abomasal-omasal reflux with sphincters (3). 
 An accurate assessment of colonization consistency and persistency should 
incorporate not only numerical data, but also the phases of colonization, which can be 
52 
 
divided into three functional stages: 1) initiation (days 0-6), 2) early persistence or 
maintenance (days 7-14), and 3) long term persistence (>14 days).  Support for this 
concept in this field is documented by Hovde and colleagues (28, 30), in which culture 
positivity for one week or less indicates the lack of a stable association between the host 
and bacterium.  Colonization consistency, especially in the early maintenance phase, 
appears to be a significant problem in bovine E. coli O157 colonization models.  In a 
selective review of three studies in which cattle were orally or ruminally colonized with 
1010 cfu/animal, there were 6 out of 10 (30), 8 out of 12 (14), and 9 out of 9 (4) culture 
positive animals at days 12, 12-14, and 14, respectively. Furthermore, in the former two 
studies (14, 30) in which animal-specific shedding levels were reported, culture-positive 
animals at 25 days post-infection and beyond were the same animals positive at days 12-
14 the majority of the time.  Although this meta-analysis is not statistically validated, 
visual inspection of these data sets indicates that culture positivity at days 12-14 is a 
strong predictor of long term persistence.  Improved consistency and persistence was 
observed in a novel rectal administration model (30).  In this study, 8 of 8 animals 
inoculated rectally with 109 cfu were positive at day 14 and most were persistently 
culture positive through 6 weeks (30). 
 Although prioritizing adult cattle E. coli O157 colonization models over young 
calf models has been justified, it does not come without concomitant problems, the most 
significant of which is cost.  The purchase price and per diem maintenance costs of adult 
cattle are significantly higher than analogous costs with young calves, and such expense 
usually has the effect of sample size restriction.  Because sample sizes are generally 
smaller, this places greater emphasis upon consistency to achieve appropriate statistical 
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power.  It also focuses greater interest on the possibility of repeated colonization of adult 
cattle for use in multiple colonization trials.  This is particularly important with respect to 
the use of duodenally cannulated cattle as described herein.  Single repeat colonizations 
of cattle with E. coli O157 have been demonstrated in two studies (4, 14).  However, 
these repeat colonizations relied upon natural elimination of the pathogen (4) and/or a 
lengthy interval between colonizations (4, 14).  Adapting a colonization protocol to the 
chemotherapeutic elimination of the organism and decreasing the time interval between 
colonizations minimizes experimental costs for use of adult cattle for colonization 
studies.   
 The terminal rectal mucosa of cattle has recently been identified as a site of 
tropism for E. coli O157 colonization (23).  This known tropism provides an important 
sampling site for colonization or surveillance studies.  In a more recent study, researchers 
found that a rectoanal mucosal swab from this site exhibited superior sensitivity over 
other samples when monitoring colonization (28).  In the model described herein, 
acquired samples included feces as well as rectal mucus.  This latter sample is analogous 
to the rectoanal mucosal swab (30).  Sampling of mucus was further based upon prior 
research that demonstrates that E. coli and other microflora grow preferentially in mucus, 
rather than feces (11, 37).  
 In this study, we present an E. coli O157 colonization model effective in adult 
cattle.  The advantages of novel features of this model are discussed.  In the development 
of this model, we investigated the following: 1) the success of colonization via a 
duodenal cannula, 2) the effect of streptomycin treatment upon colonization success, 3) 
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the difference between fecal shedding and rectal mucus recovery, and 4) the possibility of 
using the same animals for repeated colonization trials. 
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Materials and Methods 
Research Animals/Environment.  Five mixed-breed beef cattle (4 steers, 1 heifer) were 
purchased at approximately 227kg body weight and allowed to acclimatize to their initial 
environment, the Oklahoma State University Veterinary Teaching Hospital.  Duodenal 
cannulas were placed 6cm caudad to the pyloric junction and anchored and exteriorized 
between the last two ribs following a published technique (33).  Cattle were maintained 
on injectable broad-spectrum antibiotics for one week and daily cannula site Betadine 
rinses for two weeks.  During experimental colonizations, animals were transferred to and 
maintained in a BSL-2 large animal facility; each animal was placed in a pen alone.  
Researchers wore BSL-2 personal protective equipment; additional animal care personnel 
wore face shields and masks during high pressure spray cleanings.  Pens were scraped 
daily; feces were collected and treated with household bleach (1 part bleach to 9 parts 
fecal matter) for a minimum of four hours prior to disposal in the sewage system.  Pens 
were spray-washed once daily with an antimicrobial mixture. Cattle were fed twice daily 
a pelleted total mixed ration composed of corn, ground alfalfa hay, and mineral 
supplements.  Water was provided free choice.  At termination of experiments, cattle 
negative by enrichment culture for E. coli O157 were temporarily transferred to an 
outdoor facility and maintained similarly while the BSL-2 facility was cleaned. 
Bacterial strain and inoculation preparation.  E. coli O157 EDL 933 used was 
streptomycin-resistant and nalidixic acid-resistant and was provided by Dr. Paul Cohen of 
the University of Rhode Island.  Bacteria were grown overnight in 250mL of Luria broth 
(Sigma) to an OD600 of 1.5-1.6.  For inoculation, 100mL of cell suspension was pelleted 
and washed three times with PBS and finally resuspended in 50mL of PBS.  Ten-fold 
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dilutions of the final inocula were prepared and plated with spreading on selective SMAC 
media (described below) to accurately assess the inoculation level. 
Inoculation, Streptomycin treatment.  For inoculation, an EMT endotracheal tube 
(Bound Tree Medical, Dublin, OH) was placed in the opened cannula followed by cuff 
inflation for sealing.   Each animal received 10mL of the prepared inoculum via the 
medicinal access port of the EMT tube followed by 5mL flush of PBS via the same port 
followed by a 40-120mL flush of PBS via the main lumen of the EMT tube.  No loss of 
the inoculating bolus was ever observed.  For cattle on daily streptomycin treatment, a 1 
g/mL solution of streptomycin sulfate (Sigma) in water was prepared and dosed via the 
cannula at 15mg per pound of body weight.  On the morning of colonization initiation, 
streptomycin treatment was delayed approximately 12 hours until the evening sampling.  
Cattle receiving daily streptomycin began the treatment regimen three days prior to 
colonization and continued until the colonization was terminated. 
Sampling/Media.  Samples of feces and rectal mucus were collected at 0, 0.5, 1, 2, 3, 5, 
7, 9, 12, 15, and 18 days.  Fecal samples ranged from 5-20g and were collected either as 
free-catch samples or directly from the terminal rectum.  Feces was weighed and 
suspended at a 1:10 ratio in 1% tryptone (Becton-Dickinson) and placed on ice for one 
hour prior to plating.  Mucus samples were acquired from the rectum via palpation; 
briefly, following manual evacuation of the feces, mucus was collected from the ventral 
half of the most caudal 30 cm of the rectum by scraping with the lid from a sterile syringe 
casing.  Mucus was scraped until 200-500mg was acquired; it was suspended at a 1:2 
ratio in 1% tryptone, vortexed vigorously, and placed on ice for one hour prior to plating.  
Feces and mucus samples were processed into 10-fold dilution series by diluting 100µL 
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of initial sample into 900µL of sterile PBS, and 100µL of each dilution was placed onto 
appropriate agar media and evenly spread on the plate with an alcohol-flamed spreading 
tool.  Bacterial plates were incubated 12-18 hours at 37°C prior to assessment and 
counting.  Diluted feces and mucus samples were plated onto two types of media:1) 
Sorbitol-MacConkey (SMAC) agar (Remel) and 2) SMAC agar with the following 
antibiotics added: streptomycin at 40µg/mL and nalidixic acid (Sigma) at 50µg/mL.  
Sorbitol-negative (white) colonies were enumerated daily and, where colonial 
morphology was unusual, subjected to confirmatory testing with a commercially 
available immunoassay (O157 Immunocard STAT; Meridian Biosciences).  Enrichment 
cultures accompanied all daily samplings.  Briefly, 100-150µL of primary samples were 
placed in TSI broth (Becton-Dickinson) with 40µg/mL streptomycin and grown at 37°C 
for 16 hours with shaking (210 rpm).  If primary samples were negative, the enrichment 
samples were subjected to dilution series and plated similarly.  Enrichment samples 
yielded qualitative data of presence (enrichment positive) or absence (enrichment 
negative).  For purposes of computation of means, enrichment data were transformed to a 
semi-quantitative estimate of 50 cfu/g feces or 10 cfu/g mucus, exactly 50% of the lowest 
limit of detection for each of the sampling regimens. Rectal biopsies were taken at days 
0, 3, 9, and 15 of each colonization trial.  Biopsies were procured in the terminal 3cm of 
rectum via an equine uterine biopsy instrument and fixed in 10% buffered neutral 
formalin.  Tissues were routinely processed, paraffin embedded, sectioned, and stained 
with hematoxylin and eosin, and examined by light microscopy. 
Colonization termination.   At the conclusion of an experiment, cattle were treated with 
two antibiotics to which the colonizing strain was determined to be susceptible.  
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Neomycin (Biosol; Upjohn) was administered daily for three days via the cannula at 10 
mg/kg.  Ceftiofur sodium (Naxcel; Pfizer) was administered subcutaneously daily for 
three days at 0.5mg/kg.  Enrichment cultures of the last day of such treatment and two 
subsequent days were grown, plated, and assessed to determine reliable elimination of the 
colonizing strain. 
Terminal Study/Euthanasia and Necropsy Methods.  In the final colonization trial, 3 
groups of animals were colonized and then euthanized: Group I, euthanized at one-day 
post-colonization (n=1), Group II, euthanized at three days post-colonization (n=2), and 
Group III, euthanized at seven days post-colonization (n=2).  To prevent unintentional 
early colonization, animals were penned according to their planned date of euthanasia 
and separated by a minimum of 20 feet.  During this terminal study, steer #3 (assigned to 
group II) experienced sudden, severe, free gas bloat on the third post-colonization day 
that resulted in death before treatment could be administered.  This was presumed to be 
due to, in part, its predisposition to bloat and its dominance during feeding with the co-
penned smaller steer.  The other four cattle were sedated with xylazine (Rompun, Bayer) 
and killed with a captive-bolt gun.  Necropsy followed a standard protocol and was 
performed by an American College of Veterinary Pathologists board-certified 
pathologist.  Contents from the rumen, abomasum, duodenum, ileum, cecum, proximal 
colon, and feces were diluted and plated identically for that described for feces above.  
Gall bladder contents and mucus from duodenum, ileum, cecum, proximal colon, and 
terminal rectum were diluted and plated identically to that described above for rectal 
mucus.  Tissues examined by light microscopy were fixed in 10% buffered neutral 
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formalin, processed through graded alcohols, sectioned at 5µm, stained with hematoxylin 
and eosin, and coverslipped.   
Statistical Methods.  Two groups were compared for the effect of daily streptomycin 
treatment.  A fair toss of the coin determined the unequal initial assignments of animal 
numbers per group (streptomycin treated n=3; no treatment n=2).  Animals assigned to 
each group were determined by chance.  In the second phase of the experiment, the 
groups and assignments were reversed, creating a balanced, paired experiment.  The 
Wilcoxon-signed ranks test, a non-parametric statistical test, was utilized in a one-tailed 




Animal health.  All animals remained healthy throughout the course of the five repeated 
colonizations.  Occasional animals would experience transient, moderate bloat during the 
termination of colonization trials.  This was presumed to be secondary to the effects of 
the two antibiotics given.  The cannula of one steer became broken and displaced during 
the course of one experiment and was replaced.  Sporadic diarrhea was noted in variable 
animals but did not correlate with any colonization event.  All cattle experienced 
moderate average daily gains of 0.71 +/- 0.05kg over the 221 days of these studies.  No 
attaching and effacing histopathology was recognized in any cow during the course of the 
colonizations or the necropsy study. 
Streptomycin treatment benefited colonization success.  To test the effect of 
streptomycin upon experimental colonization, five study animals were randomly assigned 
to a streptomycin-treated group (n=3) and a non-treated control (n=2) and colonized per 
cannula identically.  After 18 days of sampling, the colonization was terminated with 
antibiotics, a “washout” period ensued, and the group assignments were reversed, 
creating a paired experiment.  Figures 1A and 1B summarize the recovery of the input 
strain in a time-relative fashion for feces and mucus, respectively.  For analysis of the 
effect of streptomycin, colonization phases were defined as initiation (days 2, 3, and 5), 
early maintenance (days 7, 9, and 12), and late maintenance (days 15 and 18).  
Streptomycin treatment favored the magnitude of shedding in mucus during initiation 
(p<0.01) and early maintenance (p=0.02), but not late maintenance (p>0.10).  
Streptomycin treatment favored the magnitude of shedding in feces only during initiation 
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(p<0.01) with levels in early maintenance and late maintenance deemed insignificant 
(p>0.05 and p>0.15, respectively). 
Greater persistence of recovery and increased magnitude of shedding was seen in 
mucus samples instead of feces samples.  Feces and rectal mucus samples were 
procured and subjected to dilution and plating at every sampling day.  Greater persistence 
of recovery was seen in mucus than feces during the two-phased trial that tested the effect 
of streptomycin (Figures 1A and 1B).  In determination of persistence, days of 
persistence was defined as the last sample day positive unless a minimum of two 
intervening samples were negative between two positive samples.  The latter situation 
was negated as it possibly implied a re-infection from another animal.  When cattle were 
streptomycin-treated, E. coli O157 persistence was 16.8 +/- 2.7 days in mucus and 14.0 
+/- 4.6 days in feces.  Likewise, when not streptomycin-treated, E. coli O157 persistence 
was 15.6 +/-2.5 days in mucus and 9.8 +/- 5.4 days in feces.  In analyses of the other 
three trials in which streptomycin was in continuous use (Tables 1 and 2), the input strain 
was recovered in mucus for 13.13 +/- 3.25 days and in feces for 10.93 +/- 3.97 days 
(Wilcoxon-signed rank test: p≤0.02).   Higher magnitude of shedding was seen in mucus 
over feces at day 2 (p<0.025), day 3 (p<0.005), and day 5 (p<0.05), but magnitude of 
shedding was not significantly different between feces and mucus at days 7, 9, 12, and 
15.   
Colonization was reproducible and amenable to repetition within animals.  Five full-
length trials of 15 or 18 days were conducted on the same five animals.   Upon examining 
bacterial recovery from mucus across all five trials, 92% of all samples were positive at 
day 9, 84% of all samples were positive at day 12, and 72% of all samples were positive 
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at day 15.  A period of time ranging from 6 days to 4 weeks intervened between the 
termination of one colonization trial and the beginning of a subsequent trial.  No 
diminished colonization magnitude or persistence was seen in any subsequent trial.  
Indeed, the latter two full-length trials conducted exhibited 100% positive shedding in 
mucus at day 15.  
The lower intestinal tract quickly became the primary site of localization.  A sixth 
and final colonization trial was conducted on these cattle to spatially define colonization 
sites in a temporal fashion within this model.  Cattle were colonized via the cannula and 
euthanized at 1 day (n=1), 3 days (n=2, 1 euthanized, 1 died), and 7 days (n=2) post-
colonization.  Following euthanasia (or death, steer #3), gross necropsy was performed, 
and thirteen samples were procured for primary and enrichment cultures. Significantly, 
no retrotranslocation of the input strain was detected in the abomasum or the rumen 
(Table 3).  The input strain was recovered from the gall bladder in three of the five cattle.  
Overall, the highest magnitude of recovery was seen in the rectal mucus samples.  
However, this was not true for steer #5, which exhibited enrichment positivity in many 
samples even though it was terminated at only 24 hours post-colonization.  This animal 
received a one-log order of magnitude lower colonization bolus which could explain the 
reduced recovery.  Overall, it was evident that within seven days, the terminal rectum 
became the primary site of localization with ileal mucus being a secondary site of 
recovery.  It is also evident that the colonizing bolus was cleared from the duodenal 
cannulation site very quickly, being only detected in the animal sacrificed at 1-day post-
colonization.  Histopathologic samples of various gastrointestinal and gall bladder sites 




 A primary goal of developing an improved bovine colonization model for the 
study of E. coli O157 is a model that consistently yields reliable and reproducible 
establishment of colonization.  The streptomycin-treated cow model described here 
exhibits several positive attributes consistent with this goal.  Additionally, compared to 
other bovine E. coli O157 colonization models, the model described here is novel in three 
respects: 1) colonization initiation via the duodenal cannula, 2) facilitation of niche 
occupation by the continuous streptomycin treatment, and 3) repeated use of the same 
cattle for repeated colonization experiments.   
 The most significant positive attribute of the streptomycin-treated cow E. coli 
O157 colonization model is its reliability and reproducibility.  Adult cattle are more 
difficult to experimentally colonize than calves, and this difficulty is observed in the 
areas of shedding levels and proportions of positive study animals after one week post-
inoculation (1, 4, 14, 24, 30).  The shedding levels of these streptomycin-treated cattle at 
7 and 15 days post-inoculation (101 to 104 and 101 to 103, respectively) were similar to 
those found in other published adult cattle colonization models.  Further, the 
streptomycin-treated cow model appears comparable or slightly superior to other adult 
models with respect to proportions of positive study animals after one week of 
colonization.  In four of five trials, 100% of the cattle in this model were actively 
shedding at day 12.   In the remaining trial, 100% were actively shedding through 7 days.  
Also, colonization persisted in all five animals for 15 days in at least one of the trials.  
For comparison, Cray and colleagues showed that nine of nine orally colonized adults 
were actively shedding at 14 days (4).  Experiments performed by Sheng and colleagues 
64 
 
showed that six of ten orally colonized cattle were positive on day 12, but eight of eight 
rectally colonized cattle were positive at day 14 (30).  Additionally, twelve of eighteen 
orally dosed adults were positive at day twelve to fourteen in a study by Grauke and 
colleagues (14).  Further difficulty in adult colonization was documented by Ohya (24) 
and Buchko (1) in which 4 of 8 calves and 9 of 18 yearling steers, respectively, were 
fecal culture negative by 7 and 9 days, respectively.  
 Repetitive colonizations of the same individual animals were demonstrated here.  
We successfully colonized the same five animals five (six, including the terminal 
experiment) times without significant variations of shedding levels and proportions 
colonized.  Repetitively colonizing the same animals had been demonstrated before (4, 
14), and in those studies, cattle were reinoculated once instead of the five times 
demonstrated here.  In one study (4), there was a significant drop in the persistence of 
colonization upon re-inoculation, but the other study demonstrated no differences in 
shedding patterns following re-inoculation (14).  Furthermore, re-inoculation in those 
studies (4, 14) followed a lengthy interval to allow for the natural elimination of E. coli 
O157.  In contrast, the strain and methods employed herein allowed for reliable 
chemotherapeutic elimination of E. coli O157 followed by re-colonization without 
diminished success.  The measured lengths of persistence in the other studies (4, 14) 
extend beyond the 15 to 18 days measured here, so a direct comparison is not possible.  
Regarding the immune response of cattle to E. coli O157, Johnson and colleagues 
demonstrated that the serological responses of cattle were not correlated with elimination 
or reinfection with E. coli O157 (18).  Their findings implied that persistence and 
reinfection in the face of an immune response contributed to herd persistence and that 
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vaccine-based interventions could be of questionable efficacy (18).  The repetitive 
colonizations demonstrated here seem to add additional weight to that argument.  
 Administration of the colonizing bolus via the duodenal cannula conferred the 
principal advantage of avoiding ruminal dilution of the bolus.  Whether or not the 
traversing of ruminal contents (estimated to be 100-120L in these animals) impacts 
colonization success is not known and was not tested here.  However, the data acquired 
from the streptomycin-treated cows are more similar to the rectal administration model 
(30) than to the oral and/or ruminal colonization models (4, 14, 30).  The results of this 
study and the rectal colonization model seem to indicate that experimental colonization 
success is negatively impacted by transit of the upper gastrointestinal tract.  To further 
support this idea, conditions simulating rumen fluid of well-fed animals have been shown 
to negatively affect growth of E. coli O157 (26).  Also relevant to the discussion is the 
bypass of the acidic abomasal environment in the streptomycin-treated cow model.   In 
Salmonella typhimurium, adaptation to acidity influences the expression of full virulence 
(reviewed in (12)).  A similar adaptive response may occur in E. coli O157 in the bovine 
gastrointestinal tract, and this model would provide the means to test such a hypothesis.  
 Streptomycin effected a dramatic reduction of susceptible facultative anaerobic 
bacteria by six log-orders of magnitude in the murine E. coli O157 colonization model 
(36).  However, although the results indicated a beneficial effect of streptomycin upon E. 
coli O157 colonization success, such a magnitude of reduction was not appreciated in the 
streptomycin-treated cattle, where two log-orders of magnitude (106 to 104 cfu/g) 
reduction was usually observed (data not shown).  The reasons for this difference could 
be: 1) a higher proportion of naturally streptomycin-resistant microflora in cattle than in 
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mice, 2) the cumulative acquisition of resistance by facultative anaerobes in the present 
study, 3) the much larger volume of the bovine intestine and its subsequent dilution of the 
antibiotic, or 4) the acidity of the bovine rectum diminishing the efficacy of the drug (17).   
 In the terminal colonization trial, site-specific localization and magnitude of E. 
coli O157 colonization was assessed.  Most significantly, the greatest magnitude of 
bacterial recovery, on average, was in the terminal rectal mucus, lending additional 
support to the findings of Naylor and colleagues that the terminal rectal mucosa is a site 
of tropism for E. coli O157 (23).  However, the consistent recovery of E. coli O157 from 
ileal mucus or feces was partially at odds with the Naylor study (23) although animals in 
that study were younger and sacrificed at 3-4 weeks post-colonization.  Ileal recovery 
parameters for these streptomycin-treated cows are most similar to the results in sheep 
reported by Grauke (14).  Both the terminal rectal mucosa and ileum are characterized as 
being rich in lymphoid tissue, and this feature may be important for the confirmed and 
suspected areas of tropism for E. coli O157.  Gall bladder recovery of the input strain was 
demonstrated in three of this study’s animals, a finding that corroborates previous work 
by Stoffregen and colleagues (32).   
 In sampling feces as well as mucus scraped from the terminal rectum, it was 
demonstrated that rectal mucus samples yielded higher magnitudes of shedding during 
early colonization and also resulted in longer term recovery of the organism.  This 
method of sampling and improved recovery of E. coli O157 is broadly similar to the 
rectoanal mucosal swab culture method described by Rice and colleagues (28).  However, 
the basis for mucus sampling in the present study was the body of evidence indicating 
that generic E. coli resides in the mucus layer of the intestine and metabolizes mucin-
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derived sugars (2, 37).  Further, in the development of the murine E. coli O157 
colonization model, Wadolkowski and colleagues demonstrated that murine cecal and 
colonic mucus supported growth of E. coli O157 EDL 933 (36), the strain used in the 
present study. 
 The novel methods employed by this E. coli O157 colonization model should not 
be construed as specific for E. coli O157 studies.  The streptomycin-mediated reduction 
of competing flora, coupled with bacterial colonization via a duodenal cannula could be 
beneficial and should be amenable to other bacterial colonization studies in cattle, 
provided that the input strains are streptomycin-resistant. 
 Thorough discussion of the model would be incomplete without a discussion of 
disadvantages.  The expense of this model is the chief disadvantage.  A principal 
contributor to the expense – usage of adult animals – is inferred to the goals of the model 
development and cannot be altered.  Other factors contributing to the expense include the 
cost of cannulation surgery and the antibiotics used to facilitate or eliminate 
colonizations.  Another disadvantage is its labor intensity.  The frequency of sample 
acquisition, the frequency of streptomycin treatment, and the maintenance and protection 
of the cannulas are chief contributors to the labor intensity of the model.  The chief 
compensation for these disadvantages is the reproducible and repetitive colonizations of 
animals, with a fully realized goal of decreased animal usage and expense. 
 This study demonstrated an advance in the understanding of E. coli O157 
colonization of adult cattle.  It demonstrated the reproducibility conferred by novel 
methods, the effect of reducing competitive flora, and the repetitive colonization of the 
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same animals.  The model should serve as a useful alternative when other investigators 
seek to advance the understanding of E. coli O157 and its bovine reservoir. 
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Figure 1.  Streptomycin-treated and non-treated animals were colonized with 1010 cfu of 
E. coli O157 and samples were taken at the indicated times, homogenized, and 
plated as described.  Enumerated counts were transformed to log10 levels.  A) 
Monocolonization in feces.  B) Monocolonization in mucus.  Bars represent the 
standard error of the log10 (cfu/g sample).  Value at day 0 reflects samples 
acquired at 12 hours post-colonization. 
 
Table 1. 
TABLE 1.  E. coli O157 concentrations within feces of streptomycin-treated adult cattle 
 
E. coli O157 concentrationa (CFU/g feces) on post-inoculationb day:  
 
Animal 
#/Sex  0.5 (12 hrs)    1      2 3 5 7 9 12 15
1/M 5.9 X 107 7.0 X 104 9.0 X 102 2.0 X 102 E+     0 E+ 5.0 X 102 0 
2/F 5.8 X 105 1.1 X 104 1.0 X 103 4.0 X 102 E+     E+ 0 0 0
3/M 6.4 X 107 9.4 X 104 2.3 X 104 1.0 X 103 4.0 X 102 0 E+ 2.0 X 102 0 




5/M 3.9 X 105 7.0 X 104 2.5 X 103 1.3 X 103 7.0 X 102 0    E+ 0 0
1/M 2.0 X 105 1.8 X 104 2.4 X 103 1.8 X 103 1.0 X 103 5.0 X 102 E+ 1.2 X 103 6.0 X 102
2/F 1.3 X 106 1.5 X 103 1.1 X 103 6.0 X 102 1.0 X 102 2.0 X 102 2.1 X 103 9.5 X 102 2.5 X 102
3/M 8.9 X 106 8.8 X 104 1.0 X 103 1.0 X 102 2.3 X 103 E+    0 E+ 0




5/M 8.4 X 105 2.2 X 104 2.6 X 103 2.5 X 102 4.5 X 103 3.0 X 102 1.3 X 103 3.5 X 102 9.0 X 102
1/M 3.4 X 106 6.0 X 102 2.0 X 102 2.5 X 102 2.0 X 102 4.0 X 102 3.0 X 102 0  0
2/F 1.6 X 105 3.6 X 103 1.3 X 103 5.0 X 102 E+ 4.5 X 102 E+ 1.2 X 103 E+ 
3/M 3.9 X 105 5.3 X 103 4.0 X 102 1.0 X 102 E+ 2.0 X 102 0   0 0




5/M 1.6 X 106 4.0 X 103 1.6 X 103 5.5 X 102 3.5 X 102 1.8 X 103 1.0 X 102 1.1 X 103 0 
a Values rounded to two significant figures and expressed in scientific notation;  E+: positive by enrichment culture only; 0: not 
detected by primary or enrichment cultures. 







TABLE 2.  E. coli O157 concentrations within rectal mucus of streptomycin-treated adult cattle 
 
E. coli O157 concentrationa (CFU/g rectal mucus) on post-inoculationb day:   
    
Animal
#/Sex  12 hrs 1      2 3 5 7 9 12 15
1/M 9.0 X 105 1.0 X 105 5.8 X 104 9.6 X 102 1.0 X 102 1.4 X 102 E+   0 0
2/F 1.1 X 106 5.6 X 103 4.8 X 102 6.0 X 101 1.8 X 102 E+    0 0 0
3/M 1.4 X 107 8.2 X 104 9.2 X 103 1.1 X 103 5.8 X 102 5.2 X 102 2.4 X 102 3.6 X 102 5.0 X 102




5/M 2.3 X 105 3.2 X 104 1.7 X 103 1.4 X 103 1.0 X 102 1.5 X 103 E+   0 0
1/M 4.8 X 105 5.6 X 103 1.1 X 104 2.7 X 103 5.8 X 102 1.4 X 102 2.2 X 102 6.0 X 102 E+ 
2/F 2.7 X 106 1.5 X 105 7.6 X 102 1.1 X 103 4.1 X 104 4.2 X 103 4.4 X 102 2.8 X 102 3.8 X 102
3/M 6.4 X 106 7.8 X 104 3.5 X 104 6.9 X 104 2.9 X 104 8.0 X 101 8.0 X 101 2.3 X 102 3.2 X 102




5/M 3.9 X 105 1.1 X 104 6.8 X 103 1.5 X 103 1.2 X 103 1.0 X 102 3.0 X 102 5.0 X 101 5.6 X 102
1/M 1.3 X 106 4.4 X 103 4.5 X 103 1.5 X 103 1.6 X 103 1.2 X 103 2.6 X 103 3.4 X 102 2.0 X 101
2/F 3.2 X 105 1.4 X 104 9.6 X 102 1.2 X 103 5.2 X 102 3.8 X 102 E+ 1.8 X 102 8.0 X 101
3/M 1.8 X 105 6.2 X 103 8.4 X 102 7.8 X 102 2.3 X 103 4.8 X 102 3.0 X 101 1.4 X 103 1.2 X 102




5/M 4.9 X 105 4.6 X 104 3.4 X 103 7.8 X 102 9.2 X 102 7.4 X 102 1.0 X 102 2.0 X 102 8.0 X 101
a Values rounded to two significant figures and expressed in scientific notation;  E+: positive by enrichment culture only; 0: not 
detected by primary or enrichment cultures. 




Table 3.   
 
 
TABLE 3.  E. coli O157 localization by time in the streptomycin-treated cow model 
 
E. coli O157 concentrationa (CFU/g sample) 
Days Post-Inoculation: 1b 3c 7c
Sample Site ID 5/Steer   2/Heifer 3/Steer 1/Steer 4/Steer
Rumen, Abomasum 0, 0 0, 0 0, 0 0, 0 0, 0 
Gall bladder E+     E+ 0 0 E+
Duodenum Contents 1.0 X 102 0    0 0 0
Duodenum Mucus E+     0 0 0 0
Ileum Contents 4.0 X 102 3.0 X 102 2.1 X 103 7.0 X 102 8.0 X 102
Ileum Mucus E+ 2.0 X 101 1.2 X 103 1.0 X 102 1.1 X 103
Cecum Contents  1.0 X 102 0 0 7.0 X 102 E+ 
Cecum Mucus E+ E+ 4.0 X 101 8.0 X 101 E+ 
Prox. Colon Contents E+ 1.0 X 102 0 1.0 X 102 2.0 X 102
Prox. Colon Mucus E+ E+ 2.0 X 101 4.0 X 101 6.0 X 102
Feces E+ 2.0 X 102 1.4 X 103 2.0 X 102 1.0 X 102
Rectal Mucus E+ 8.2 X 102 6.0 X 101 4.7 X 103 6.2 X 102
a Values rounded to two significant figures and expressed in scientific notation;  E+: positive by enrichment culture only; 0: not 
detected by primary or enrichment cultures. 
b  Steer #5 was dosed with 109 cfu of E. coli O157 via the duodenal cannula. 
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 The gram-negative bacterium E. coli O157 causes human intestinal illness with 
occasional fatal systemic sequelae.  The most important reservoir of E. coli O157 is the 
bovine intestinal tract, and fecal shedding is the usual source of E. coli O157 
contamination of food.  However, comparatively little is known about factors important 
for its colonization of the bovine intestine.  Prior animal colonization models have 
established a tropism for the terminal bovine rectum and the modest importance of 
adhesins such as intimin and long polar fimbriae.  In this study, we investigate whether a 
nutritional basis exists for colonization of the bovine rectum by E. coli O157.  This was 
investigated by competitively co-colonizing streptomycin-treated adult cows with a wild-
type strain of E. coli O157 and an isogenic mutant in a catabolic pathway for either 
ribose, N-acetylgalactosamine, or fucose.  Strains were streptomycin-resistant and had 
additional antibiotic selectable markers for the differential enumeration of input strains 
sampled from terminal rectal mucus.  All three catabolic knockout strains exhibited 
modest to marked colonization defects during initiation (days 0-6).  The fucose catabolic 
knockout exhibited the greatest colonization defect during maintenance (days 7-15), the 
ribose catabolic knockout exhibited a modest colonization defect during late maintenance 
(days 12-15), and a colonization defect was not appreciated during maintenance for N-
acetylgalactosamine.  These results support the idea that growth and colonization of E. 
coli O157 in the bovine rectum has a nutritional basis, with a nutrient preference for 







 The gram-negative bacterium E. coli O157, an intestinal pathogen of man that 
causes diarrhea, hemorrhagic colitis, and the occasionally fatal hemolytic-uremic 
syndrome (21), was first associated with human illness in 1982 when an outbreak of 
diarrhea was associated with the consumption of undercooked, contaminated ground beef 
(26).  Outbreak investigations and research performed since have established bovine-
origin food products as the primary vehicle of infection, cattle as the principal reservoir, 
and bovine fecal shedding as the primary mode of food contamination.  Because of the 
importance of the bovine reservoir and fecal shedding to the disease epidemiology, the 
colonization of cattle by E. coli O157 has been extensively studied (6, 7, 9, 14, 22, 29).  
Recently, the large intestine (14) and the rectum (22) were identified as sites of high 
magnitude recovery following experimental E. coli O157 colonization of adult cattle.  
However, the underlying factors impacting bovine colonization by E. coli O157 are not 
known.  The steps involved in the colonization of the intestinal mucosa are proposed to 
include chemotaxis and motility, penetration of the mucus layer, adhesion to mucin-
derived oligosaccharides within the mucus layer, adhesion to epithelial surfaces, and 
growth and catabolism (reviewed in (5, 17)).   These factors frame some of the recent 
research on adhesion and the study on sugar catabolism described herein. 
 Adhesion of E. coli O157 to epithelium has been recently reviewed (32).   The 
outer membrane protein intimin and its translocated intimin receptor Tir, both encoded 
within the locus of enterocyte effacement (LEE) pathogenicity island, are important 
mediators of attaching and effacing (A/E) histopathology (6, 9, 10, 21, 34).  Intimin is 
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important in the colonization of neonatal calves (9), young adult cattle (6), sheep (6, 34), 
and neonatal pigs (10).  The importance of LEE was reaffirmed in a recent examination 
of bovine E. coli O157 colonization factors studied by colonizing a library of signature-
tagged mutants (11).   In conventional pigs, E. coli O157 with long polar fimbriae 
mutations (lpfA1 and lpfA2) exhibited modest colonization defects and fewer A/E lesions 
than the wild-type parent (15).  The O-polysaccharide side chain of E. coli O157 may 
play a role in the colonization process (23), but is not required for attachment (4).  Non-
fimbrial adhesins encoded by toxB and efa-1, potentially important in E. coli O157 
adherence, remain to be fully functionally characterized (reviewed in (32)).   
 A role for growth and nutrient catabolism in successful colonization is best 
explained by Freter’s hypothesis, which holds that the 500-1000 different species of the 
gut microbiota can stably coexist as long as each constituent successfully competes for 
one or a few limited nutrients, and that their growth rate is at least equal to their intestinal 
washout rate (3, 5, 13).  Nutrient sources include ingested food, shed epithelia, and 
intestinal mucins (3).  Intestinal mucins, macromolecular glycoproteins that comprise the 
major protein component of intestinal mucus (27, 28), are produced mainly by goblet 
cells, provide nutrient sources (3, 5) and attachment sites (16) for bacteria, and have gel-
forming properties (28) that protect intestinal mucosa (27, 28).  Mucins consist of a 
protein backbone extensively glycosylated by O-linked oligosaccharides of marked 
structural and compositional diversity (27, 28).  These oligosaccharides contain five 
major sugars: L-fucose, D-galactose, sialic acids, N-acetylgalactosamine, and N-
acetylglucosamine (5).   Other sugars detected in mucus, originating from sloughed 
epithelium, diet, or bacterial metabolism, include arabinose, ribose, gluconate (5), and 
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mannose (5, 19).  Evidence from recent studies indicates that commensal E. coli strains 
occupy the intestinal mucus layer (18, 25) and catabolize sugars present in mucus (3, 5).  
Similarly, Wadolkowski and colleagues demonstrated  in vitro growth of E. coli O157 
EDL 933 in murine colonic mucus (33).  Therefore, E. coli O157 catabolism of sugars 
present in rectal mucus may be important to its colonization of the bovine rectum.  
 In this study, we examined the nutritional basis of E. coli O157 bovine rectal 
colonization by hypothesizing that E. coli O157 catabolizes mucin-derived sugars during 
its colonization of that site.  We tested this hypothesis by competitively co-colonizing 
wild-type E. coli O157 with isogenic mutants deficient in catabolic pathways for two 
mucin-derived sugars (L-fucose and N-acetylgalactosamine) or another sugar present in 
mucus (ribose) and monitored for colonization defects by differentially enumerating the 
E. coli O157 strains in rectal mucus.   Herein, we report the results of these three trials. 
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Materials and Methods 
Research animals and environment.  Five mixed-breed beef cattle (4 steers, 1 heifer) 
were purchased at approximately 227kg body weight and allowed to acclimatize to their 
initial environment, the Oklahoma State University Veterinary Teaching Hospital.  
Duodenal cannulas were placed 6cm caudad to the pyloric junction and anchored and 
exteriorized between the last two ribs following a published technique (30).  Cattle were 
maintained on injectable broad-spectrum antibiotics for one week and daily cannula site 
Betadine rinses for two weeks.  During experimental colonizations, animals were 
transferred to and maintained in a BSL-2 large animal facility; each animal was placed in 
a pen alone.  Research personnel wore BSL-2 personal protective equipment; additional 
animal care personnel wore face shields and masks during high pressure spray cleanings.  
Pens were scraped daily; feces were collected and treated with household bleach (1 part 
bleach to 9 parts fecal matter) for a minimum of four hours prior to disposal in the 
sewage system.  Pens were spray-washed once daily with an antimicrobial mixture. Cattle 
were fed twice daily a pelleted total mixed ration composed of corn, ground alfalfa hay, 
and mineral supplements.  Water was provided free choice.  At termination of 
experimental trials, cattle experienced mild, transient bloat secondary to antibiotics.  
Further, at trial termination, cattle were temporarily transferred to an outdoor facility and 
maintained similarly while the BSL-2 facility was cleaned. 
Bacterial strain and inoculation preparation.  E. coli O157 EDL 933 (wild-type) used 
was streptomycin-resistant and nalidixic acid-resistant.  Isogenic mutants in catabolic 
pathways for ribose, N-acetyl-galactosamine, and L-fucose were constructed in the 
streptomycin-resistant E. coli O157 EDL 933 with a chloramphenicol resistance cassette 
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inserted into the gene of interest following a published method (8).  A summary of strains 
used and their source is in Table 1.  Polymerase chain reaction verified the correct 
insertion, and growth on appropriate minimal media confirmed the phenotype.  For 
colonization, all strains were grown for 16 hours in 200mL of Luria broth (LB, Sigma) to 
an OD600 of 1.5-1.6.  Growth curves for the wild-type and isogenic mutant strains in LB 
broth were identical and reproducible and allowed for reasonably accurate predictions of 
inoculation levels for both strains.  An input ratio of 3-4:1 favoring the mutant was 
chosen to more conclusively demonstrate the colonization defects of the mutants.  For 
inoculation, 60mL of wild-type cell culture and 200-240mL of mutant cell culture was 
pelleted and washed three times with PBS and finally resuspended in 50mL of PBS.  Ten-
fold dilutions of the final bolus were prepared and plated with spreading on selective 
SMAC media (described below) to accurately assess the inoculation level. 
Inoculation and streptomycin treatment.  For inoculation, an emergency medical 
technician (EMT) endotracheal tube (Bound Tree Medical) was placed in the opened 
cannula followed by cuff inflation for sealing.   Each animal received 10mL of the 
prepared inoculum via the medicinal access port of the EMT tube followed by 5mL flush 
of PBS via the same port followed by a 40-120mL flush of PBS via the main lumen of 
the endotracheal tube.  No loss of the inoculating bolus was ever observed.  Cattle were 
treated daily via the cannula with streptomycin prepared as a 1 g/mL aqueous solution of 
streptomycin sulfate (Sigma).  Cattle were dosed 15 mg/lb of body weight beginning 
three days prior to initiation of colonization and continued until termination of a trial. On 
the morning of colonization initiation, streptomycin treatment was delayed approximately 
12 hours until the evening sampling.   
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Sampling and media.  Samples of feces and rectal mucus were collected at 0, 0.5, 1, 2, 
3, 5, 7, 9, 12, and 15 days.  Fecal samples ranged from 5-20g and were collected either as 
free-catch samples or directly from the terminal rectum.  Feces was weighed and 
suspended at a 1:10 ratio in 1% tryptone (Becton-Dickinson) and placed on ice for one 
hour prior to plating.  Mucus samples were acquired from the rectum via palpation; 
briefly, following manual evacuation of the feces, mucus was collected from the ventral 
half of the most caudal 30 cm of the rectum by scraping with the lid from a sterile syringe 
casing.  Mucus was scraped until 200-500mg was acquired; it was suspended at a 1:2 
ratio in 1% tryptone, vortexed vigorously, and placed on ice for one hour prior to plating.  
Feces and mucus samples were processed into 10-fold dilution series by diluting 100µL 
of initial sample into 900µL of sterile PBS and so forth.  100µL of each dilution was 
placed onto appropriate agar media and evenly spread on the plate with an alcohol-
flamed spreading tool.  Bacterial plates were incubated 12-18 hours at 37C prior to 
assessment and counting.  Diluted feces and mucus samples were plated onto three types 
of media: 1) Sorbitol-MacConkey (SMAC) agar (Remel), 2) SMAC agar with 
streptomycin at 40ug/mL and nalidixic acid (Sigma) at 50 ug/mL (NS-SMAC), and 3) 
SMAC agar with streptomycin at 40ug/mL and chloramphenicol (Sigma) at 34 ug/mL 
(CS-SMAC).  Colonies enumerated on SMAC media reflected total flora supported by 
growth on MacConkey before and during streptomycin treatment and also monitored for 
introduction of non-input E. coli O157 strains (which was not detected).   NS-SMAC was 
used for the differential enumeration of wild-type E. coli O157; CS-SMAC was used for 
differential enumeration of mutant strains of E. coli O157.   Sorbitol-negative (white) 
colonies were enumerated daily and, where colonial morphology was unusual, subjected 
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to confirmatory testing with a commercially available immunoassay (O157 Immunocard 
STAT; Meridian Biosciences).  Enrichment cultures accompanied all daily samplings.  
Briefly, 100-150µL of primary samples were placed in trypticase soy infusion (TSI) broth 
(Becton-Dickinson) with streptomycin (40 µg/mL) and grown at 37C for 16 hours with 
shaking (210 rpm).  If primary samples were negative, the enrichment samples were 
subjected to dilution series and plated similarly.  Enrichment samples yielded qualitative 
data of presence (enrichment positive) or absence (enrichment negative).  For purposes of 
computation of means, enrichment data was transformed to a semi-quantitative estimate 
of 50 cfu/g feces or 10 cfu/g mucus, exactly 50% of the lowest limit of detection for each 
of the respective samples.    
Colonization termination.   At the conclusion of an experiment, cattle were treated with 
two antibiotics to which the colonizing strains were determined to be susceptible.  
Neomycin (Biosol; Upjohn) was administered daily for three days via the cannula at 10 
mg/kg.  Ceftiofur sodium (Naxcel; Pfizer) was administered subcutaneously daily for 
three days at 0.5mg/kg.  Enrichment cultures of the last day of such therapy and two 
subsequent days were grown, plated, and assessed to determine reliable elimination of the 
colonizing strain. 
Statistical Methods.  In the three competitive co-colonization trials described, colonies 
were counted on differential media, converted to a log10 scale, means for the five cows 
computed, and a standard error of the log10 data computed.  The initiation phase of 
colonization was defined as days 2, 3, and 5 of sampling, excluding the 12 and 24 hour 
samples because transient intestinal passage and equilibration of the inoculum was 
occurring.  The maintenance phase of colonization was defined as days 7, 9, 12, and 15.  
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The Wilcoxon-signed ranks test, a non-parametric statistical test, was utilized in a one-
tailed fashion to test for significant differences during colonization phases, with p<0.05 
deemed significant.  The null hypothesis was that co-colonizations of wild-type and 
mutant strains would be equal.  The alternative hypothesis tested was that the mutant 




Animal Health.  All animals remained healthy and experienced moderate average daily 
gains of 0.74 +/- 0.07kg over the 98 days of these studies.  No attaching and effacing 
histopathology was observed in any of the cattle during the course of the colonizations. 
Ribose is important in the late maintenance phase of colonization and may be 
important during initiation.  Wild-type E. coli O157 was co-colonized with E. coli 
O157 ∆rbsK, a mutant constructed with a chloramphenicol resistance cassette disrupting 
the ribokinase (rbsK) gene.  The mutant:wild-type input ratio was 3.96:1, and both strains 
were differentially enumerated in feces and rectal mucus over 15 days (Figure 1).  We 
artificially favorably biased all mutants at the point of colonization to ensure a minimum 
of a 1:1 ratio of input strains and to allow the possible development of a ratio reversal to 
be demonstrated. The ratio reversed to 0.5:1 by day 3 (Figure 2).  In addition to the ratio 
reversal, the wild-type was recovered in significantly higher numbers than the mutant in 
the aggregate analysis of days 2, 3, and 5.  During the entire maintenance phase the 
average number of wild-type organisms recovered was higher than the mutant (p<0.05).  
However, upon examining days 7 and 9 (p=0.065) and 12 and 15 (p<0.01) in separate 
analyses, it appeared that the later maintenance phase was more important than early 
maintenance.  All five animals were positive for both strains within mucus through day 
12, but on day 15, all five were positive for the wild-type while only two were positive 
for the mutant.  Results for the feces samples were similar through day 9.  Fecal 
persistence for both strains beyond day 9 was sporadic (data not shown). 
N-acetyl-galactosamine may be important in initiation of colonization. Wild-type E. 
coli O157 was co-colonized with E. coli O157 ∆agaWEFA, a mutant constructed with a 
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chloramphenicol resistance cassette replacing a portion of the phosphotransferase (PTS)-
dependent import system (agaWEF) and the de-acetylase (agaA) gene for N-
acetylgalactosamine.  The mutant:wild-type input ratio was 4:1, and strains were 
differentially enumerated in feces and rectal mucus over 15 days (Figure 3). The 4:1 ratio 
reversed to 0.69:1 by day 3 (Figure 4).   Consistent with this observation, the wild-type 
was recovered in higher average numbers than the mutant on days 2, 3, and 5 (p<0.05).  
In aggregate analysis of sample days within the maintenance phase, there was no 
significant difference in recovery of bacteria between the two strains (p>0.2).  By day 15, 
one animal each was negative for one of the strains within rectal mucus.  Therefore, there 
was no significant difference in persistence observed between the wild-type and mutant 
strain.  The fecal shedding data was similar in the progressive, day-to-day, decrease in 
recovery and in the lack of a significant difference during maintenance.  However, the 
day-to-day differences between the strains during maintenance fluctuated more widely 
(data not shown).   
Fucose is important in initiation and maintenance phases of colonization.  Wild-type 
E. coli O157 was co-colonized with E. coli O157 ∆fucAO, a mutant constructed with a 
chloramphenicol resistance cassette disrupting the fucose aldolase (fucA) and oxido-
reductase (fucO) gene for fucose catabolism.  The mutant:wild-type input ratio was 3.8:1, 
and both strains were differentially enumerated in feces and rectal mucus over 15 days 
(Figure 5).  The input ratio of 3.8:1 reversed markedly to 0.03:1 on the third day of this 
trial (Figure 6).  In aggregate analysis of samples collected during the initiation phase, the 
wild-type was recovered in mucus in significantly higher numbers than the fucose mutant 
(p<0.01).  Similarly, in aggregate analysis of maintenance phase samples, the wild-type 
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was recovered in mucus in significantly higher numbers than the fucose mutant (p<0.01).  
Persistence of the wild-type strain was 9.4 +/- 3.3 days, and persistence of the mutant was 
4.8 +/- 2.3 days (p<0.05).  Overall, fecal shedding of both strains was only somewhat 
similar to the mucus recovery, being of generally lower magnitude and shorter duration 




 Cattle were successfully co-colonized with parent and isogenic catabolic mutant 
strains of E. coli O157 EDL933 in this study.  Mutants were constructed in key 
carbohydrate source catabolic pathways and, with the aid of antibiotic selectable markers, 
were differentially enumerated with the parent strain in feces and rectal mucus with a 
frequent sampling regimen.  This system permitted the in vivo observation of 
colonization defects in the complex and dynamic large intestinal environment.  The 
rational selection of appropriate catabolic mutants was guided by results of similar 
competitive colonizations in CD-1 mice (Cohen, P.S. and Conway, T., unpublished) and 
by selected literature (11, 19).  
 The contribution of ribose to the nutritional basis of E. coli O157 cattle 
colonization was shown to be important during initiation and of modest importance 
during late maintenance.  By comparison, similar experiments in CD-1 mice showed that 
the rbsK mutant exhibited a three-log order of magnitude colonization defect in 
competition with its wild-type parent at day 11 (Cohen, P.S. and Conway, T., 
unpublished), displaying the importance of E. coli O157 ribose catabolism to a higher 
degree than that observed in the adult cattle model.  Such an effect is likely not generic to 
all E. coli as ribose was the least preferred nutrient for commensal E. coli MG 1655 (3) in 
similar experiments in CD-1 mice.  Ribose does not appear to be mucin-derived; instead, 
it is detected in mucus (5) and is likely derived from nucleic acids of sloughed epithelium 
and dead microorganisms.   Its modest importance in adult cattle E. coli O157 
colonization could possibly be reflective of limited compositional availability in the 
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mucus layer.  Unfortunately, the contribution of ribose to the available pool of sugars 
within animal mucus has not been analyzed in many previous studies (19, 27, 28, 31).  
 N-acetylgalactosamine (Aga) was demonstrated to be of modest importance 
during initiation, but not during maintenance.  Overall, this was broadly similar to the 
finding that Aga was of minor importance to E. coli O157 in the CD-1 mice (Cohen, P.S. 
and Conway, T., unpublished).   A preliminary conclusion from these results in cattle is 
that Aga is not essential for growth during the maintenance phase.  Other alternative 
mechanisms for not observing a maintenance defect could have been: 1) limited sugar 
availability, or 2) redundancy in catabolic pathways.  The compositional proportion of 
Aga in bovine intestinal mucin was ~24% in a study of young calf ileal mucin (19).  
Similar data is not available for other sites or other ages of cattle.  Therefore, proportional 
availability of Aga in the adult bovine rectum is not known.  Interestingly, Dziva and 
colleagues colonized young calves with signature-tagged mutants of E. coli O157 and 
found a colonization defective mutant with a transposon insertion in agaB, annotated to 
be a portion of the phosphotransferase (PTS) - dependent import pathway for Aga. 
(Disparate gene annotation exists as Brinkkotter and colleagues indicate agaB to be part 
of the PTS import pathway for galactosamine, not Aga (2).)  Additional commentary on 
the construction of the mutant, E. coli O157 ∆agaWEFA, provides a relevant background 
to discuss catabolic pathway redundancy.  Disruption of agaWEF eliminated genes of the 
Aga-specific PTS import pathway (2), and disruption of agaA eliminated the gene for the 
deacetylase step, the first degradative step following import (2).  Therefore, catabolic 
pathway redundancy both in Aga importation and deacetylation would need to exist to 
fulfill this mechanistic possibility.    
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 The competitive co-colonization involving the fucose mutant demonstrated a 
marked colonization defect in initiation and maintenance.  The underlying mechanism for 
this defect may reflect: 1) a critical importance of fucose as a carbon source for E. coli 
O157 , 2) that fucose may be the dominant glycan in the region sampled, or 3) both.   
Support for the former mechanism comes from the competitive co-colonization of the 
same strains in CD-1 mice.  In that study, competitive co-colonization of wild-type E. 
coli O157 with E. coli O157 ∆fucAO demonstrated the most dramatic colonization defect 
in the fucose mutant when compared to several other competitive co-colonizations 
(Cohen, P.S. and Conway, T., unpublished).  These results are highly similar to the adult 
cattle colonization results contained herein.   This is likely not a generic E. coli 
phenomenon as a similar catabolic knockout constructed in E. coli MG 1655 was 
competitively co-colonized in CD-1 mice, and the fucose knockout demonstrated a less 
dramatic colonization defect.  Furthermore, fucose was ranked as the sixth (of seven) 
most preferred nutrient for E. coli MG1655 in in vitro growth experiments (3).  In 
consideration of the second possible mechanism, whether fucose is the dominant glycan 
of bovine rectal mucin, there is no published analysis of bovine rectal mucin.  However, 
fucose is a minor constituent of calf ileal mucin (19).   
 Returning to Freter’s hypothesis, that successful colonization is predicated upon 
successfully competing for one or a very few limited nutrients while having a growth rate 
that exceeds intestinal washout (3, 5, 13), it appears that fucose may be a preferred 
nutrient for E. coli O157 colonization of the bovine rectum.  A corollary of this idea is 
that the transient occurrence of E. coli O157 shedding documented in field settings could 
be partially explained by initial colonization by heavy fecal contamination (advanced by 
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Cray and Moon (7)) followed later by other microflora occupying a fucose nutrient-niche 
displacing E. coli O157 by virtue of more efficient utilization of fucose or a higher 
growth rate.  Furthermore, probiotic strategies aimed at limiting fucose bioavailability 
could possibly limit the successful colonization of E. coli O157 in the bovine rectum and 
may be a rational application of these results .   
 The composition of bovine rectal mucin could be a determinant of unknown 
significance upon these results.  In the young calf, Aga and fucose were major and minor, 
respectively, constituents of ileal mucin (19), yet if sugar availability dictates nutrient 
preferences, one could hypothesize that these levels of Aga and fucose would be reversed 
in adult cattle rectal mucin.  Indeed, one cannot generalize mucin oligosaccharide 
composition from the calf ileum to the adult bovine rectum because differences likely 
exist.  In comparative studies, mucin has been shown to exhibit regionally specific 
patterns of glycosylation in rodents (12, 31) and man (27, 28).  Further, expression of 
glycosyltransferase genes is regionally specific in rodents, as well (20).  Robbe and 
colleagues suggest that such regionally specific mucin glycosylation could be explanatory 
for colonization of specific intestinal regions by bacteria (tropism) by virtue of a diversity 
of attachment sites (27).  In addition and as an alternative, we speculate that such 
regionally specific glycosylation could possibly be a factor in defining nutrient-niches 
and even regional tropisms for bacteria.   
 In a recent study, the lymphoid-dense, terminal rectal mucosa was identified as a 
site of tropism for E. coli O157 colonization of cattle (22), and Naylor and colleagues 
speculated that the tropism was likely based on a bacterial adhesin-epithelium receptor 
interaction occurring at this site (22).  Attaching and effacing histopathologic lesions 
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have been demonstrated in rectal and colonic mucosal explants (1) and ileal explants (24) 
in adult cattle.  In vivo attachment in an adult cow was first demonstrated by Naylor and 
colleagues in the rectum (22).  The wide-ranging spatial occurrence of E. coli O157 
attachment to ileum (24), colon (1), and rectum (1, 22) calls into question the likelihood 
that adhesin-mediated attachment is the principal defining factor in the terminal rectal 
tropism.  Certainly, the present study does not conclusively present an alternative 
hypothesis.  However, a nutritional basis for colonization of E. coli O157 may be 
spatially variable and could be a factor defining colonization tropism.  Future studies 
using additional competitive co-colonizations, as well as biochemical definition of bovine 
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Figure 1.  Competitive Co-colonization in Mucus: E. coli O157 WT and E. coli 

































Figure 1.  Streptomycin-treated cattle were colonized with 1010 cfu of wild-type E. coli 
O157 and E. coli O157 ∆rbsK and mucus samples were taken at the indicated 
times, homogenized, and plated as described.  Enumerated counts were 
transformed to log10 levels.  Bars represent the standard error of the log10 (cfu/g 
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Figure 2.  The absolute numerical ratio of input strains E. coli O157 WT and E coli O157 
∆rbsK recovered in mucus over time during initiation.  Plot is the average of ratio 
of strain by input or recovery for five adult cows.
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Figure 3.  Competitive Co-colonization in Mucus: E. coli O157 WT and E. coli 

































Figure 3.  Streptomycin-treated cattle were colonized with 1010 cfu of wild-type E. coli 
O157 and E. coli O157 ∆agaWEFA and mucus samples were taken at the 
indicated times, homogenized, and plated as described.  Enumerated counts were 
transformed to log10 levels.  Bars represent the standard error of the log10 (cfu/g 
sample).  Value at day 0 reflects samples acquired at 12 hours post-colonization.
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Figure 4.  The absolute numerical ratio of input strains E. coli O157 WT and E coli. O157 
∆agaWEFA recovered in mucus over time during initiation.  Plot is the average 
of ratio of strain by input or recovery for five adult cows.
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Figure 5. Streptomycin-treated cattle were colonized with 1010 cfu of wild-type E. coli 
O157 and E. coli O157 ∆fucAO and samples were taken at the indicated times, 
homogenized, and plated as described.  Enumerated counts were transformed to 
log10 levels.  Bars represent the standard error of the log10 (cfu/g sample).  Value 



























Figure 6.  The absolute numerical ratio of input strains E. coli O157 WT and E coli O157 
∆fucAO recovered in mucus over time during initiation.  Plot is the average of 
ratio of strain by input or recovery for five adult cows.
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Table 1.  Strains utilized in this study. 
 
 
Strain Antibiotic Resistance Source 
E. coli O157 EDL933 WTa Strb, Nalc
E. coli O157 ∆fucAO Str, Camd
E. coli O157 ∆agaWEFA Str, Cam 
E. coli O157 ∆rbsK Str, Cam 
P. Cohen, Univ. of 
Rhode Island 





Aptamer Selection for 








Background/Objective:  E. coli O157 is an intestinal pathogen of man that causes 
diarrhea and the hemolytic-uremic syndrome.  It is usually transmitted in food 
contaminated by bovine feces. Because of its public health importance, novel diagnostic 
tools with advantages in speed, sensitivity, cost, and field adaptability are in demand.  
Aptamers, oligonucleotides selected from random pools for desired affinities, have the 
potential to satisfy these demands.  Aptamers can bind targets in a manner similar to 
antigen-antibody interactions, with similar to superior specificity, dissociation constants, 
and repertoire.  We have performed aptamer selection experiments (SELEX) against E. 
coli O157 targets with the goal of identifying useful binding species.  Methods:  In one 
targeting strategy, E. coli O157 lipopolysaccharide was purified, biotinylated, and 
immobilized on streptavidin-coated paramagnetic particles.  Multiple rounds of SELEX 
were performed on this target with DNA and RNA aptamer pools. Nitrocellulose 
immobilization of purified lipopolysaccharide was also attempted for target presentation.   
In a second targeting strategy, whole E. coli O157 cells were used as a target, and E. coli 
K-12 and other Enterobacteriaceae were used as negative selection targets. Partitioning of 
binding ligands was performed by centrifugation.  Radiolabeled aptamer binding assays 
and cloning and sequencing enriched pools were strategies utilized to monitor progress.   
Results:  Selective enrichment of the aptamer pool was not observed during the targeting 
of immobilized lipopolysaccharide.  However, selective enrichment of the pool was 
observed through 19 rounds of SELEX against E. coli O157 whole cells.  Additionally, a 
binding assay indicated 5:1 preferential binding for O157 over K-12, and the enriched 
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aptamer bound O157 in a significantly greater proportion than the round 0 background.  





 E. coli O157 is an intestinal pathogen of man that causes bloody diarrhea and the 
occasionally fatal hemolytic-uremic syndrome.  It is currently estimated that E. coli O157 
causes more than 70,000 illnesses with 60 deaths annually in the U.S. [1]  It is also 
prioritized by the U.S. Centers for Disease Control (CDC) as a category B bioterrorism 
agent (http://www.bt.cdc.gov/agent/agentlist.asp).   Because of the public health 
importance of E. coli O157, robust diagnostic tools that exhibit superior performance 
with respect to speed, cost, and field adaptability without sacrificing specificity and 
sensitivity are especially needed.  This introduction will briefly review the current state of 
diagnostic testing for E. coli O157 (for more detail, see [2-4]) and illustrate the unique 
properties and potential applications of aptamers for the detection and surveillance of E. 
coli O157. 
 Basic clinical microbiological detection of E. coli O157 is achieved by using the 
sorbitol-MacConkey media (SMAC), recommended by the CDC to be routinely used in 
the culture of bloody diarrhea specimens [5]. SMAC, selective for the presumptive 
diagnosis of E. coli O157 [6], differentially identifies E. coli O157 because its inability to 
ferment sorbitol confers a colorless colonial morphology [6], whereas ≥ 80% of E. coli 
are sorbitol fermenters and appear pink [7].  The specificity of this technique is 
problematic as sorbitol-fermenting, E. coli O157 strains have been documented [8, 9].   
 Diagnostics based on chromosomal and/or plasmid DNA content of E. coli O157 
have been reviewed [3] and utilize unique genetic signatures in either probe-based assays 
or the polymerase chain reaction.  Recently, specific primers for the O157 O-antigen 
biosynthesis genes were designed resulting in a PCR technique specific for the detection 
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of E. coli O157 [10].  Perhaps more clinically relevant are PCR techniques targeting 
Shiga toxin genes or the eae gene from the locus of enterocyte effacement (reviewed in 
[3], because these genes are specific for the larger group of enterohemorrhagic E. coli, 
instead of restricted to E. coli O157.  The higher expense and increased technical 
expertise required for PCR somewhat restricts its application in primary diagnostics.  
 Immunomagnetic separation and latex agglutination testing are diagnostic tools 
that exhibit high specificity and require less technical expertise.  Immunomagnetic 
separation is a technique based upon commercially available paramagnetic particles 
(Dynal) that are derivatized with O157 monoclonal antibodies.  Immunomagnetic 
separation with these particles has been successfully used to detect E. coli O157 in food  
[11, 12], water [12], cattle feces [13], and human feces [14], with markedly greater 
sensitivity of detection in cattle feces [13] and human feces [14].   Latex agglutination 
testing is accomplished via several end-user, marketed kits.  In one study, three such kits 
were evaluated by testing 159 strains of E. coli (O157 and other serotypes).  The 
sensitivity and specificity were both 100% when compared to internal reference sera [15].  
The primary pitfall for both immunomagnetic separation and latex agglutination (as well 
as other immunoassay techniques) is the serologic cross-reactivity of E. coli O157.  
Indeed, E. coli O157 O antigen has identical or cross-reactive epitopes with E. coli O44 
and O55 [16], Brucella abortus, Salmonella O30 strains[17], Yersinia enterocolitica, 
Citrobacter freundii, Citrobacter sedlakii [18], Escherichia hermannii [19],  and some 
non-O1 strains of Vibrio cholerae [20].  
 As an alternative to antibody-based techniques, aptamers have been proposed to 
be developed and utilized in diagnostic testing for infectious agents [21], including E. 
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coli O157.  Aptamers are DNA or RNA oligonucleotides that bind a target of interest on 
a physicochemical and electrostatic basis [22], in contrast to traditional usage of 
oligonucleotides as hybridization probes.  Here, in addition to a genotype, the aptamer 
possesses a phenotype in its exhibition of affinity and selectivity for targets.  An aptamer 
selected to bind thrombin is perhaps the most successful and certainly most-studied in 
this emerging class of biomolecules [23], but aptamers have also been selected against 
polysaccharides, small molecules, and whole cells (reviewed in [22]).  Aptamers are 
selected from complex, synthetic, oligonucleotide pools by an iterative process known as 
SELEX (systematic evolution of ligands by exponential enrichment) [24].  Each iteration 
(“round”) results in affinity partitioning of winning ligands, which are then amplified via 
PCR and subjected to subsequent rounds.  To date, little has been published in the area of 
aptamer selection for bacterial targets except for two reports on aptamers for anthrax 
toxin [25] and E. coli O111 LPS [26].  Thus, if aptamer selection for bacterial targets is 
increasingly successful, their binding properties and other advantages could make them a 
useful alternative to antibodies in the future. 
 To select an aptamer specific for E. coli O157, we chose to target the bacterial 
outer membrane because it is predominantly comprised of the immunodominant 
lipopolysaccharide [27, 28] and because any selected aptamer could be applied in a 
diagnostic platform without a need for cellular disruption.  Two targeting strategies were 
employed.  In the first, the purified lipopolysaccharide (LPS) from E. coli O157 was 
utilized as a target and, in the second, whole E. coli O157 cells were utilized as the target, 
presenting an array of potential, externally-presented targets.  Herein, we report the 
progress made on aptamer selection for E. coli O157. 
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Materials and Methods 
Bacterial strains.  E. coli O157 ATCC 43888 is a Shiga-toxin negative strain isolated 
from human feces.  It produces a fully substituted O antigen.  E. coli O157 MA6, a gift of 
Choong Park, VA Fairfax Hospital, Falls Church, VA, is a naturally occurring, rough 
mutant of E. coli O157 [29].  It was isolated from Malaysian beef.  It does not produce 
the O antigen, as detected by serologic tests and lipopolysaccharide analyses.  It does 
group with E. coli O157 strains on various genotypic analyses.  E. coli TOP10F’ is a K-
12 derivative (Invitrogen).  Salmonella typhimurium used was a bovine fecal isolate from 
the archives of the Oklahoma Animal Disease Diagnostic Laboratory.  Yersinia pestis 
KIM5 D1 was a gift of Dr. Robert Brubaker, Michigan State University.  The former two 
bacteria were used in lipopolysaccharide purification and targeting.  E. coli O157 43888 
and the latter three isolates were used for whole cell selections.  Luria/glycerol stocks of 
both strains were prepared and archived at -80°C.  Standard dilutions were used to 
present known quantities of cells for whole cell selection experiments. 
Lipopolysaccharide Extraction.  Lipopolysaccharide (LPS) was extracted from 
bacterial cells using a protocol supplied by Andrew Preston, Centre for Veterinary 
Science, University of Cambridge.  This protocol is a modification of the hot 
phenol:water extraction process described by Johnson and Perry [30].  Bacteria were 
inoculated into 2L of Luria broth (Sigma) for 16 hours of growth.  Cells were harvested 
with centrifugation at 7,500 rpm for 15 min and washed three times with ddH20.  Water 
sufficient to make a thick slurry was added, and the suspension was sonicated with a 
Branson Sonifier 450 with the following parameters: Output-8; Duty cycle-constant; 
pulse-constant; 30 second pulses for a total of 90 seconds.  Lysozyme (Sigma) was added 
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to 0.2% w:v and the suspension incubated at room temperature overnight followed by a 
24 hour incubation at 4°C.  Next, the suspension was sonicated for an additional 30-
second pulse using the above conditions.  Micrococcal nuclease (30U, Sigma) and 
ribonuclease A (100µg/mL, Sigma) was added, and the suspension was incubated at 4°C 
an additional 48 hours. Phenol (Sigma) was melted and equilibrated with the bacterial 
digest at 65°C.  It was sonicated for 30 sec and incubated an additional 30 minutes.  Next, 
the suspension was placed on ice for 30 minutes and then centrifuged at 6000 rpm at 4°C.  
The aqueous phase was removed, an equal volume of water was added to the phenol 
phase, and the heat incubation, ice, and centrifugation were repeated.  Both aqueous 
phases were pooled, the phenol phase was recovered, and both phases were extensively 
dialyzed against ddH20 for 3-7 days using dialysis tubing (15,000 MWCO, cellulose 
acetate, SpectraPor).  Dialysis proceeded until the phenol odor was non-detectable.  
Volumes from both dialyzed phases were then ultracentrifuged at 100,000xg in a 55.2Ti 
rotor and Beckman ultracentrifuge for 16 hours at 4°C.  The pellet was collected, 
resuspended in ddH20 and subjected to an 8 hour proteinase K (Sigma) digestion (25 
mg/mL PK prepared and added to LPS solution at 100µL per 500µL) at 60°C.  The final 
preparation was lyophilized to result in a dry product utilized in future analyses and 
modifications. 
Other LPS Sources:  LPS from E. coli O55 (Sigma) was utilized as supplied.  
LPS Analysis by SDS-PAGE.  Lipopolysaccharide products purified from E. coli O157 
43888 and E. coli O157 MA6 were analyzed with SDS-polyacrylamide gel 
electrophoresis.  Minigels were cast at 12.5% using Bio-Rad or Hoefer apparatus.  
Acrylamide mixtures, ammonium persulphate, TEMED, and buffering solutions used 
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chemicals from Sigma.  LPS samples were diluted into Laemmli sample buffer (Sigma) 
and boiled for 3 minutes prior to loading.  Gels were run at constant voltage (100V; 80-
110 minutes).  Gels were stained by a silver stain kit (Owl) following manufacturer’s 
instructions.  Principal of the silver stain kit was based upon Tsai and Frasch’s described 
methods [31].   
LPS Biotinylation.  Bacterial lipopolysaccharides were biotinylated following a method 
described by Luk and colleagues [32].  One milligram of LPS was dissolved in 0.9mL of 
fresh, 0.1M sodium acetate (pH 5.0) followed by addition of 0.1mL of 100mM sodium 
m-periodate (Sigma) and the overall mixture was incubated on ice for 30 minutes in the 
dark.  The reaction was stopped by addition of a drop of glycerol (~2µL).  The mixture 
was dialyzed (15,000 MWCO, SpectraPor) overnight against sterile PBS.  Next, biotin-
LC-hydrazide cross-linker (Pierce) was prepared in DMSO to a final concentration of 
50mM, and 0.1mL of this solution was added to the dialyzed, oxidized LPS sample.  This 
mixture was incubated at room temperature for 2 hours with end to end rocking and then 
dialyzed again overnight and stored at 4°C.  Successful biotinylation was confirmed by 
dot-blotting and electrotransfer (Bio-Rad transfer case) of SDS-PAGE gels onto 
nitrocellulose (0.45µm, Bio-Rad) followed by probing with a streptavidin-alkaline 
phosphatase conjugate and colorimetric detection with a BCIP/NBT substrate (Sigma).  
Streptavidin-coated paramagnetic particles.   M-270 Dynabeads (Dynal) are uniform, 
spherical, superparamagnetic, polystyrene beads with streptavidin covalently attached to 
the surface.  These beads were utilized in Dynabead-immobilized lipopolysaccharide 
target presentations and also were utilized during strand separations performed as part of 
the SELEX protocol.  Prior to utilizing beads for strand separation or for target 
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presentation, they were captured and washed two times with 1X binding buffer, described 
below. 
DNA Aptamer Library.  The DNA aptamer library utilized in most experiments was 
composed of a 23-base upstream constant primer binding site and a 20-base downstream 
constant primer binding site flanking a central, randomized region thirty nucleotides in 
length (IDT, Coralville, IA).  The sequence of the DNA library was 5’-
TTGAGCGTTTATTCTGAGCTCCC- (N) 30 – TTCGACATGAGGCCCGGATC – 3’, 
the forward primer sequence was 5’-TTGAGCGTTTATTCTGAGCTCCC, and the 
reverse primer sequence was 5’-GATCCGGGCCTCATGTCGAA.  Biotinylated reverse 
primer was utilized for polymerase chain reaction in all post-SELEX amplification except 
when it preceded planned cloning and sequencing of the pool.  Prior to cloning, the 
enriched aptamer pool was amplified utilizing the forward primer and a non-biotinylated 
reverse primer.  
DNA Aptamer SELEX for Bead-Presented LPS.  The DNA SELEX protocol is 
summarized in Figure 1A.  Biotinylated, purified LPS was loaded at a minimum of 2X 
saturating load as determined in an ELISA-like format.  LPS was loaded fresh onto 
Dynabeads prior to each round of SELEX in the presence of 1X binding buffer and 
washed three times with 1X binding buffer prior to incubation with pool. Following 
incubation with pool, unbound ligands were partitioned via magnetic capture of bead-
bound target and bound ligands and washed twice with 1X binding buffer.  Bound 
ligands were PCR-amplified for the next round of selection in the presence of bead-
bound target and amplified pool was prepared for subsequent rounds by methods 
described below.  Thirty total rounds were performed designated 1-12, 13A-21A, and 
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13B-21B.  Starting pool for subsequent rounds originated from the round number/letter 
preceding in all instances except the starting pool for rounds 13A and 13B was from 
round 12 pool.  Alterations in stringency, including altered target concentrations, 
incubation times, and negative selections, occurred round by round and are summarized 
in Table 1. 
DNA Aptamer SELEX for Nitrocellulose-Presented LPS.   The DNA SELEX protocol 
is summarized in Figure 1A.  LPS was immobilized onto nitrocellulose (0.45µm 
nitrocellulose, Bio-Rad, cut into 8mm disks with a hole-punch) filter disks by immersion 
into native LPS solutions (1mg/mL) for 2-6 hours followed by three washes with 1X 
binding buffer.  Bound aptamers were eluted by heating the membrane in 300-400µL 7M 
urea at 95-100°C for 10 minutes.  Eluted aptamer DNA was ethanol precipitated and 
amplified by PCR and prepared for the next round of selection by methods described 
below.  Alterations in stringency, including altered target concentrations, incubation 
times, and negative selections, occurred round by round and are summarized in Table 2. 
DNA Aptamer SELEX for Whole Cell Targeting.  DNA SELEX protocol is 
summarized in Figure 1A.  Ultracentrifugation was selected as the means of partitioning 
the whole cells/bound ligands from unbound ligands.  The rationale for the selection of 
this partitioning method was twofold: 1. sample tubes (8x35mm snap cap, polypropylene, 
Fisher 02-681-230) and adaptor tubes (1mL polycarbonate, Beckman 355657) used in the 
Beckman type 25 rotor under ultracentrifugation conditions (90,000 x g, 20-150 min) 
resulted in compact bacterial pellets that were not easily disturbed, and 2. 
ultracentrifugation conditions utilized were considered sufficient to co-pellet derived 
outer membrane vesicles (T. Beveridge, University of Guelph, personal communication), 
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thought to be an additionally useful target likely to be present in diagnostic samples.  
Alterations in stringency, including altered target concentrations, incubation times, and 
negative selections, occurred round by round and are summarized in Table 3. 
Binding Buffer.  The binding buffer utilized in DNA aptamer selection experiments and 
in aptamer binding assays was composed as follows: 20mM Trizma base (Sigma), 5mM 
MgCl2, and 100mM NaCl.  The pH was adjusted to 7.5.   
PCR Methods.  PCR reagents (Invitrogen) included Platinum Hot-start polymerase.   
Unless otherwise indicated, PCR cycling was performed on a Peltier-PCR engine (MJ 
Research) with the following cycling conditions: 95°C (5 minutes), 30 cycles of 95°C (30 
sec), 55°C (30 sec) and 72°C (1 min), with a final extension at 72°C for 8 min.  MgCl2 
concentration was optimized to 3.5mM.  Scale of PCR reaction was usually at 500µL (10 
tubes holding 50µL reaction volumes.) 
Amplicon Analyses and Preparation for Subsequent Rounds.  Following PCR, 
sample tubes were pooled and 500µL volume was subjected to concentration with a 
Microcon YM-30 filter (Millipore) following the manufacturer’s directions.  
Concentrated amplicon was mixed with standard 6X sample buffer and electrophoresed 
on 3.6% low-melting agarose (NuSieve, Cambrex) slab gels at 100V with Tris-acetate-
EDTA buffer.  Post-electrophoresis staining was by SYBR-gold (Molecular Probes) 
following manufacturer’s directions, and gels were documented by a gel documentation 
system.  The 73-bp amplicon was carefully excised with a clean razor blade and gel 
purification was accomplished by using a commercial kit (QIAEX II, Qiagen).  
Manufacturer’s instructions for the kit were followed except for the amount of Qiaex II 
particles were increased to 40-50µL.  Following elution of dsDNA from the Qiaex II 
123 
 
particles, 200µL of M-270 Dynabeads were prepared (see below) and concurrently, the 
dsDNA aliquot was heated to 95-100°C for 5 minutes and flash-cooled in an ice-ethanol 
bath and carefully transferred to the Dynabeads.  Aptamer pool was incubated in the 
presence of Dynabeads for 5-10 min at 4°C, followed by magnetic capture of beads and 
recovery of the single-stranded, positive-sense, supernatant.  This pool was utilized in the 
subsequent round of SELEX. 
End-Labeling.  For aptamer binding assays, oligonucleotide pools or oligonucleotides of 
interest were 5’ end-labeled with γ33P-ATP (EasyTides, Perkin-Elmer, NEG612H) using 
T4 polynucleotide kinase (OptiKinase, USB) following a protocol adapted from [33].  
Briefly, 4-10 pmoles of oligonucleotide were incubated with T4 kinase, radiolabeled 
ATP, kinase buffer, and ddH20 in a total volume of 50µL at 37°C for 30-45 minutes.  
Purification of end-labeled oligonucleotides was by Sephadex G-25 columns 
(Amersham) following the manufacturer’s directions.  Incorporation efficiency was 
calculated using a standard method. 
DNA Aptamer Binding Assays.  Binding assays were performed at periodic intervals 
for all DNA based selections.  Without exception, the methods and environment of the 
binding assay conditions were similar to the selection conditions.  All aptamers were end-
labeled as described above.  For Dynabead-bound lipopolysaccharide binding assays, 
standard quantities and loads of Dynabead-bound lipopolysaccharide were incubated with 
enriched round aptamers and beginning round 0 aptamers.  Following a period of 
binding, Dynabeads were pelleted with brief centrifugation and captured with a magnet.  
Unbound supernatant and three washes with binding buffer, representing the nonbound 
fraction, were collected and analyzed on a scintillation counter.  Radiolabeled aptamers 
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bound to target were counted by analyzing the entire mixture of beads, target, and bound 
aptamers.  The percent bound represented bound counts divided by the sum of bound and 
unbound counts, multiplied by 100.  For nitrocellulose-based selections, a similar binding 
assay occurred upon nitrocellulose with bound aptamers detected by direct counting of 
the nitrocellulose disk.  Other parameters such as washing and calculations were similar 
to the Dynabead-based binding assay.  For whole cell selections, the binding assay was 
ultracentrifuge-based and differed from the two prior assays in that five washing steps 
with binding buffer occurred instead of three.  Bound aptamers were detected by direct 
counting of the bacterial pellet.  For all types of assays, negative controls consisted of 
analyzing the round 0 background and false targets.   
Cloning and Sequencing.  A TOPO-TA Cloning Kit (Invitrogen) with supplied 
chemically competent E. coli K12 TOP10F’ cells was utilized to clone enriched aptamer 
pools.  The manufacturer’s protocol was followed and modifications supportive of 
improved cloning for libraries were followed (prolonged cloning step).  Transformed 
cells were grown on Luria agar supplemented with 80µg/mL ampicillin (Sigma).  White 
colonies were grown overnight in Luria broth in deep-well plates or tubes and plasmid 
DNA was extracted with a FastPlasmid kit (Eppendorf).  Plasmid DNA was analyzed on 
a 1% agarose gel and routinely stained with SYBR-Gold (Molecular Probes) and 
documented.  Low yield or low quality plasmids were excluded from sequencing.  DNA 
sequencing was performed by the Oklahoma State University Recombinant DNA/Protein 
Resource Facility or the Oklahoma Medical Research Foundation.   
Sequence Analysis.  Following retrieval of aptamer pool sequences from a sequencing 
facility, sequences were visually inspected for quality, strand sense, vector location, 
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primer location, homology to non-input sequence data (BLAST), and length.  All 
sequences were converted to the positive sense.  Sequences with a high degree of poor 
quality sequence were excluded; those which had 1-5 uncalled nucleotides were further 
inspected by examining their electropherograms and manually corrected.  Other 
sequences excluded included those with a <21 nucleotide length of the random aptamer 
section and those with inserts from non-input genetic sources. 
 Utilized sequences were converted to FASTA format and imported to the SeqWeb 
v2.0 accelrys (GCG, Inc., Madison, Wisconsin) software suite for analyses.  Analyses 
carried out included “Pretty” (calculated consensus sequence), “PileUp” (multiple 
sequence alignments), and “GrowTree” (evolutionary relationships).   
RNA Aptamer SELEX Methods. 
RNA Aptamer Library.  The RNA aptamer library used (RNA 30N) is composed of 
1013-14 species and is synthesized at the University of Texas Ellington Lab.  Its sequence 
is GGGAAUGGAUCCACAUCUACGAAUUC(N)30 UUCACUGCAGACUUGACG 
AAGCUU where N is A, G, C, or U.  Primers used for reverse transcriptase PCR are 
41.30 (5’GATAATACGACTCACTATAGGGAATGGATCCACATCTACGA) and 
24.30 (5’ AAGCTTCGTCAAGTCTGCAGTGAA). 
Selection Strategies.  The RNA SELEX protocol is summarized in Figure 1B.  
Performed in collaboration with and at the University of Texas Institute for Molecular 
Biology (Ellington Lab), Dynabead-immobilized lipopolysaccharide from E. coli O157 
43888 was selected against with RNA aptamer pools.  The pool in use was designated 
“RNA 30N”, and SELEX was performed in an automated fashion six rounds at a time on 
a Beckman Biomek robotics station following published methods [34].  Nitrocellulose 
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binding assays used a standard technique that is more fully described in [34].  Two major 




Results and Discussion 
Lipopolysaccharide purification and analyses.  Lipopolysaccharide was extracted and 
purified using a modified hot phenol:water method.  Sodium dodecyl sulfate-
polyacrylamide gel electrophoresis followed by silver staining revealed, as expected, a 
fully substituted O antigen for the E. coli O157 ATCC 43888 as evidenced by the 
characteristic ladder-like banding pattern (Figure 2).  The E. coli O157 MA6 rough 
mutant LPS was analyzed on the same gel and revealed a similar darkly-staining, lipid A 
region, and a single band equivalent in size to the lowest ladder “rung” of the smooth 
43888 strain, and an absent ladder-like structure.  The identity of this single band is likely 
the LPS species comprised of lipid A plus inner and outer core.  The presence or absence 
of portions of the first repeat of the O antigen subunit is unknown.  The differential 
structure of the two LPS species served as the rationale for negative and positive 
selections of streptavidin-bead immobilized and nitrocellulose-immobilized LPS.  The E. 
coli O157 ATCC 43888 would serve as the positive target, and the E. coli O157 MA6 
would be the negative target, with the subtractive selection process hypothesized to 
enrich for the O antigen region. 
Selections against Dynabead-immobilized lipopolysaccharide with DNA aptamer 
pool.  Thirty rounds of SELEX were performed utilizing biotinylated E. coli O157 43888 
and MA6 LPS targets to select an aptamer specific for the fully-substituted LPS of E. coli 
O157.  Altering target concentrations, incubation parameters, and positive and negative 
targets were primary means of increasing stringency and are summarized in Table 1.   A 
binding assay was performed at round 12 and exhibited a 3.2% pool affinity for the true 
target which exceeded a negative control (bead immobilized E. coli O55 LPS) by a 2:1 
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ratio.  Further stringency alteration occurred from rounds 13A to 21A (Table 1), and most 
significantly, six SELEX rounds were performed with target-pool incubation times of 4-
10 minutes.   The round 21A binding assay showed that both E. coli O157 positive target 
and the negative control E. coli O55 bound <1% of the pool, while the unloaded 
Dynabeads bound 7.5% of the pool (Figure 3).  We speculated that the six rounds of 4-10 
minute incubations with the true target may have been disadvantageous at this stage of 
selection for the enriched round 12 pool was putatively comprised of aptamer species that 
bound best following 30-45 minute incubations, which were used during rounds 1-12.  
Conversely, the round 12 pool putatively possessed few species capable of binding so 
rapidly.  We therefore selected anew for nine additional rounds, designated rounds 13B-
21B, by using an archived round 12 pool template.  During these nine rounds, incubation 
times were lengthened back to 45-60 min, and only mild alterations in stringency were 
introduced by washing steps.  Similar to the round 21A binding assay, again the enriched 
pool (round 21B) favored unloaded Dynabead (27.3% of pool) by a 6:1 ratio over true 
target, E. coli O157 LPS.  However, assay of this pool exhibited 5.6:1 favorable binding 
for E. coli O157 LPS (4.6% of pool) over negative control, E. coli O55 LPS (0.8%). 
 The reasons for favorable binding of the unloaded bead surface in latter rounds of 
this selection are not known.  At round 21A, it was proposed that markedly shortened 
incubation times during SELEX rounds of a pool enriched under longer incubation and 
binding conditions possibly eliminated slower binders.  Although the subsequent rounds 
did not prove or disprove that speculation, certainly returning to the longer incubation 
time did not correct the problem of binding the unloaded bead.   
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 A second mechanism that could have led to the favorable binding of the bead 
surface was the methods employed to negatively control binding to the bead surface.  The 
method was simply to use the same bead for target presentation as was used for 
preparation of ssDNA (strand separation).  The operation of preparing ssDNA was to 
melt dsDNA PCR product and flash cool it as the pool was applied to the Dynabeads.  
While the Dynabeads captured the (-) sense, biotinylated ssDNA strand, the (+) sense, 
non-biotinylated ssDNA strand would be exposed to the Dynabead surface.  If the (+) 
sense ssDNA bound, then it would have been removed from future rounds of SELEX.  If 
this was ineffective, enrichment for the bead surface could occur.  Operationally, 
different temperature conditions employed for target presentation (25°C) and ssDNA 
preparation (4°C) had been utilized throughout and was speculated to be a factor that 
could have led to favored binding of the bead surface - the implication being that 
exposure of the (+) ssDNA to the beads at 4°C did not effectively control against their 
possible binding at 25°C.  The methodological problem with the negative control could 
have allowed some aptamer species to bind the bead surface during target presentation, 
and therefore undergo enrichment.  One piece of evidence that mitigates against this 
speculation is that such enrichment for the unloaded Dynabead did not occur through the 
first 12 rounds, even though identical methods were employed. 
Selections against Dynabead-immobilized lipopolysaccharide with RNA aptamer 
pool.  Concurrent with SELEX experiments using a DNA-based pool, collaborators at the 
University of Texas utilized the Dynabead-immobilized LPS from E. coli O157 ATCC 
43888 as a target for RNA selections.  Negative control targets (ie biotinylated LPS from 
E. coli O55 or E. coli O157 MA6) were not used.  Eighteen rounds of SELEX were 
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performed on an automated robotics system, and a binding assay showed 0.4% and 0.3% 
of enriched pool bound the bead-immobilized and the non-immobilized LPS, respectively 
(Figure 4).  This slightly exceeded the round 0 background for the cognate groups, but 
the levels did not exceed the background level of binding nitrocellulose by the round 18 
RNA aptamers (0.44%) (Figure 4).  An additional eighteen rounds were repeated at a 
later time with no appreciable change in the results (data not shown).  
Selections against nitrocellulose-immobilized lipopolysaccharide with DNA aptamer 
pool.   Because selections against Dynabead-immobilized LPS failed with DNA and 
RNA-based aptamer pools, and because enrichment for the Dynabead surface was 
deemed to be favored because its target properties were deemed superior to LPS, we 
sought to eliminate the introduced biotin linkage and Dynabead.  We therefore chose to 
present purified LPS species immobilized on nitrocellulose membrane disks. 
 The targets presented and selection parameters through the completed 13 rounds 
are summarized in Table 2.  Through 13 rounds of SELEX, no affinity for E. coli O157 
LPS developed when presented on nitrocellulose.  Indeed, the non-enriched round 0 
background binding level was 0.6%, and round 13 enriched pool bound E. coli O157 
LPS, E. coli O55 LPS, and E. coli O157 MA6 LPS at levels of 0.3%, 0.6%, and 0.4%, 
respectively (Figure 5).  These disappointing results were somewhat at odds with 
unpublished results of SELEX experiments targeting the LPS of Francisella tularensis.  
In these experiments, a specific aptamer for Francisella tularensis was selected by 
targeting the purified O-antigen only (N. Thirumalapura, personal communication).  This 
was performed similarly by immobilization of O-antigen upon nitrocellulose disks.  A 
key difference between these disparate results is the different nature of the whole E. coli 
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O157 LPS and the Francisella tularensis O antigen.  The nature of this difference is 
detailed further (vide infra). 
 To summarize selections against purified LPS, three major selection efforts were 
completed.   These efforts varied across two classical presentation strategies and varied 
across both DNA and RNA aptamers.  All selection efforts resulted in no affinity 
enrichment for the purified LPS target. 
 Although some details differed across selection platforms, the consensus of 
results indicated to us that the LPS target was more likely to be problematic than the 
methods employed.  Not unlike antibodies which bind to large and complex targets, 
aptamers exhibit some preferences with respect to target properties.  Favorable target 
moieties include: hydrophilicity, cationicity, and presence of sites for hydrogen-bonding 
[21].  Unfortunately, purified lipopolysaccharide is a polyanion exhibiting numerous 
phosphate groups and also possesses a large, hydrophobic lipid A moiety [27].  This 
polyanionic and partially hydrophobic nature could have made aptamer interaction highly 
disfavored thermodynamically.   Comparative data from the experiments of 
Thirumalapura and colleagues indicate that this idea may be correct.  Indeed, by 
Thirumalapura’s presentation of O antigen only, he removed the problematic moieties of 
lipid A and core that possess the disfavorable properties, hydrophobicity and 
polyanionicity.   
 Although optional strategies to compensate for disadvantageous properties of 
purified LPS existed, we instead chose to terminate the LPS selections and pursue a 
different target presentation strategy.  
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Selections against E. coli O157 and other whole bacterial cells with DNA aptamer 
pool.  With observations of low binding and other problems with LPS targeting, we chose 
to reverse our targeting approach.  The former LPS targeting strategy is best described as 
a “target in search of an aptamer.”  In contrast, we chose a strategy summarized as “an 
aptamer in search of a target” by presenting whole bacterial cells to the aptamer pool.  
Whole bacterial cells present an array of potential targets in their undisrupted form, 
including polysaccharides and protein-comprised structures such as flagella, fimbriae, 
outer membrane proteins, and porins. 
 Nineteen rounds of positive and negative selection were performed, and the 
selection strategy and alterations of stringency are summarized in Table 3.  
Ultracentrifugation was employed as the partitioning method. The round 13 binding assay 
revealed favorable binding to both E. coli O157 and E. coli K-12 (Figure 6), with 14.6% 
and 24.0% of the enriched pool binding these targets, respectively.  The round 0 
background level of binding was 4.2-6.0%, and the enriched pool showed no affinity for 
Salmonella typhimurium cells.  The higher affinity for E. coli K-12 was interesting and 
somewhat surprising in the face of negative selection against it during the first 3 rounds 
(Table 3).  We speculate that negative selection against this target in early rounds could 
have been insufficient to eliminate enriched binding for E. coli K-12.  Additionally, the 
outer membrane structure is likely very similar between E. coli O157 and E. coli K-12. 
 The round 13 pool was cloned and sequenced at this point of experimentation and 
yielded 70 clones for analysis.  Raw sequences were analyzed by DNA sequence analysis 
software and an evolutionary relationship was calculated for the sequences (Figure 7).  
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Visual inspection of this phylogenetic dendrogram revealed six broad families of 
sequences, indicative of significant pool enrichment occurring. 
 The strategy employed over the next 6 rounds (14-19) to decrease the binding for 
E. coli K-12 was to perform a two-stage selection at each round.  This was performed by 
incubating the enriched pool with E. coli K-12 cells first, followed by incubation of the 
non-binding supernatant with E. coli O157 cells, without intervening amplification via 
PCR.  Aptamer species that bound E. coli O157 after not binding E. coli K-12 were 
amplified via PCR and recycled into subsequent SELEX rounds. 
 The round 19 pool was cloned and sequenced and yielded 26 clones for analysis.  
Sequence analyses of raw sequence data resulted in a phylogenetic dendrogram that was 
dominanted by one large family with a minority of sequences in a second family. (Figure 
8)  Sequence alignment of all round 19 sequences revealed that 7 were identical and 2 
additional clones had only a single mismatch or 5’ deletion (Figure 9).  Additionally, the 
clone repeated 7 times in this analysis was also present as repeats within the round 13 
sequence analysis.  This clone, designated 2A5, was used in the final binding assay 
(Figure 10).   Finally, a conserved 11-mer motif was observed in 18/26 of the round 19 
clones.  The sequence of this 11-mer motif was CACCACMMMCM, where M is an 
abbreviation for the two nucleotides, cytosine and adenine, with an aMino group. 
 The round 19 binding assay (Figure 10) utilized the highly conserved 28-mer, 
2A5-short, as well as the 71-mer, 2A5-long (including constant primer binding sites), as 
consensus representatives of round 19.  Aptamer 2A5-long bound E. coli O157 whole 
cells at a higher level (2.5%) than 2A5-short (2.1%) and the round 0 background (1.3%), 
of which the difference between 2A5-long and background was statistically significant 
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(p<0.05).  Additionally, 2A5-long binding to E. coli O157 cells exceeded its binding to E. 
coli K-12 (0.6%) and Salmonella typhimurium (1.6%) in a statistically significant fashion 
(p<0.05).  Furthermore, the interaction of 2A5-long or 2A5-short with E. coli K-12 or 
Salmonella typhimurium was nearly identical to the round 0 background control. 
 Based upon the favorable round 13 binding for K-12 cells and the dramatically 
reduced binding affinity for K-12 at round 19, it is apparent that aggressive negative 
selection achieved its purpose.  The round 13 pool affinity for E. coli K-12 was 24% and 
exceeded background by a ratio of 4:1.  Following the six rounds of negative selection, 
the round 19 (2A5 as representative) pool affinity for E. coli K-12 was <0.5%, and was 
less than the background.  Salmonella typhimurium never exceeded its cognate negative 
control in binding assays. 
 In the round 19 binding assay, aptamer 2A5-long preferentially bound E. coli 
O157 over K-12 and Salmonella, as well as its negative control.  2A5-long also bound E. 
coli O157 at higher levels than 2A5-short.  This is interpreted as meaning that a portion 
of the upstream, downstream, or both constant primer binding sites confers upon the 
aptamer an improved binding ability. Additional assays utilizing different segments of the 
2A5 aptamer are planned to possibly further increase the binding affinity. 
 Sequence analyses performed at rounds 13 and 19 demonstrate the pool reduction 
accomplished by the SELEX protocol.  However, only binding assays can demonstrate 
the binding properties of the reduced pool.  Partially disappointing in the 2A5-binding 
assay is the overall level of aptamer binding for the E. coli O157 target.  However, this 
binding data must be interpreted cautiously.   In addition to overall low binding, it also 
illustrates a glaring deficiency in this area of aptamer research: relevant positive controls 
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for microbial surface:nucleic acid interactions do not exist.  Therefore, we cannot make 
firm conclusions regarding its binding properties, nor can we predict the ligand’s future 
utility.   
 The overall low binding of the 2A5 species for E. coli O157 cells, though 
apparently specific, is likely of low avidity.  This is partially supported by the methods 
employed in the centrifugation-based binding assay, in which five washes of the E. coli 
O157 cellular target pellet were employed.  A weakly avid aptamer species could have 
the potential to exhibit higher overall binding levels with fewer washing steps.  However, 
in our hands, we have demonstrated that five washes are necessary during this binding 
assay to eliminate a leaching effect of non-specific (possibly enmeshed) aptamers from 
the target pellet (data not shown).  Techniques to improve the binding of 2A5 to E. coli 
O157 cells are possible and are proposed to include testing different regions and fragment 
lengths of 2A5-long for improved binding and/or to possibly demonstrate higher binding 
to an isolated bacterial cellular component. 
 In summary, in vitro selection of DNA and RNA aptamers for E. coli O157 
purified LPS was not accomplished.  Though problematic target properties have been 
emphasized as possibly causative, brief commentary on general SELEX methods is 
important in summation.  The number of rounds of SELEX to isolate a binding aptamer 
in published studies ranges from a low of two rounds [35] to a high number around 
fourteen rounds [36], with many of the reports achieving aptamer isolation within 7-12 
rounds.  That the three aptamer selections against LPS took 13-21 rounds, without 
success, again points to the possibly problematic moieties of the target, but could also 
indicate methodological problems with stringency of binding and partitioning.  
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Additionally, with acquired expertise, it became apparent that simplified selection 
strategies were more appropriate than complicated iterations of positive and negative 
selections, altering target concentrations and incubation times, and the like.  The more 
simplified selection strategy developed for E. coli O157 whole cells, both in target 
presentation and a more nearly constant set of target incubation conditions, could have 
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Overall, the process is 
similar.  However, RT-
PCR is used to amplify 
the pool, and in vitro 
transcription generates 
the next pool of ssRNA.
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Legend for Figure 1. A) DNA SELEX.  SELEX is the three-step process of adsorption of 
random pool to target, partitioning and recovery of bound ligands, and amplification of 
bound ligands via polymerase chain reaction.  At the beginning, the pool complexity is 
high.  With successful enrichment, the ending pool complexity is low, though remaining 
species are high copy number.  B) RNA SELEX as specifically performed by the 
Ellington group in collaboration.  Overall, the process is similar to DNA SELEX.  
However, two key differences are: 1) reverse transcriptase (RT) PCR (RT-PCR) is used 
for amplification, and 2) amplified sequences are in vitro transcribed to RNA species 
prior to the next SELEX round.
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Figure 2.  Lipopolysaccharide SDS-PAGE analysis. 
 
 
Figure 2.  Left lane.  Fully-substituted O-antigen ladder-like structure apparent in E. coli 
O157 ATCC 43888 LPS.  Right lane.  Single band at base of region where O-antigen 
ladder should be present in rough mutant strain E. coli O157 MA6. 
145 
 
Figure 3. DNA SELEX with Dynabead-immobilized LPS. 
 
Figure 3.  Binding assays performed at rounds 12, 21 (21A), and 30 (21B). 
Percent bound indicates the percent of a radiolabeled starting pool (round 0 or enriched 
pool) bound target in a bead presentation assay.
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Figure 4.  RNA SELEX with Dynabead-immobilized LPS. 
 
Figure 4.  Binding assay performed at round 18 of automated RNA SELEX. 
Percent bound indicates the percent of a radiolabeled starting pool (round 0 or round 18 
pool) bound target in a nitrocellulose membrane presentation assay.
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Figure 5.  Binding assay performed at round 13 for nitrocellulose-presented LPS. 
Percent bound indicates the percent of a radiolabeled starting pool (round 0 or enriched 
pool) bound target in a nitrocellulose membrane presentation assay.
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Figure 6.  DNA SELEX with whole bacterial cells, round 13. 




















Figure 6.  Binding assay for whole bacterial cell aptamer selections at round 13.  Percent 
bound indicates the percent of the beginning radiolabeled round 0 or round 13 enriched 
pool that bound various targets in a centrifugation-based assay.  Error bars represent one 
standard deviation from the mean. 
149 
 




Figure 7. Phylodendritic tree computed by “GrowTree” (accelrys GCG).  Six broad 
families of sequences were visually appreciated. 
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Figure 8. Phylodendritic tree computed by “GrowTree” (accelrys GCG).  One dominant, 
highly conserved family and one smaller family of sequences was visually appreciated. 
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Figure 9.  Sequence alignment computed by “Pretty” (accelrys GCG).  Seven of these 
were identical 28-mers, and two additional sequences had only one mismatch or 5’ 
deletion.  The seven identical 28-mers were identical to the sequence repeated twice, 
2A5, in the round 13 sequence analysis.
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Figure 10.   DNA SELEX with whole bacterial cells, round 19. 
 






















Figure 10.  Binding assay for whole bacterial cell aptamer selections at round 19.  Percent 
bound indicates the percent of the beginning radiolabeled round 0 or two lengths of 2A5, 
a round 19 enriched species, pool that bound various targets in a centrifugation-based 
assay.  Error bars represent one standard deviation from the mean.
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Round LPS Target Incubation Other Comment 
1 E. coli O157 43888 30 min 2X target available 
2-6 E. coli O157 43888 30 min Decreasing target conc. 
7-9 E. coli O157 MA6 30-35 min Increasing target conc 
10-12 E. coli O157 43888 40-60 min Positive selection 
13-15A E. coli O157 43888 4 - 45 min To favor rapid binders   
16A E. coli O157 MA6 16 hrs 
17A E. coli O157 MA6 2 hrs 
Prolonged incubation to 
exclude species 
18A-21A E. coli O157 43888 4-10 min PCR Cycles: 25,20,15,30 
13B-14B E. coli O157 43888 1 hr, 1wash Began with archived R12 
15B-17B E. coli O157 MA6 45-60min 1 wash 
18B-20B E. coli O157 43888 1hr 2 washes 
21B E. coli O157 43888 1hr 3 washes 
 
Table 1. Dynabead Presentation of LPS: Targets, incubations, and other parameters. 
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Round LPS Target Incubation # of Washes 
1-4 E. coli O157 43888 90-120 min 1 
5-7 E. coli O157 43888 1 hr 2 
8 E. coli O157 MA6 1 hr 1 
9-11 E. coli O157 43888 1 hr 2 
12 E. coli O157 MA6 1 hr 2 
13 E. coli O157 43888 1 hr 3 
 
Table 2.  Nitrocellulose-presented LPS: Targets, incubation times, other parameters 
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Round Target Strategy/Comment 
1 E. coli K12 TOP10F’ Negative selection; 5 X 106 cells 
2-3 E. coli K12 TOP10F’ Negative selection; 1 X 105 cells 
4 E. coli O157 43888 4 X 104 cells; 1 wash 
5-7 E. coli O157 43888 4 X 104 cells; 2 wash 
8-10 E. coli O157 43888 4 X 104 cells; 3 wash 
11 E. coli O157 43888 3 X 104 cells; 3 wash 
12 E. coli O157 43888 2 X 104 cells; 3 wash 
13 Y. pestis KIM5 (avirulent) 1 X 106 cells; 3 wash 
14-19 Ec K-12 (1




K-12 first, then 
O157, followed 
by PCR. 
K-12: 2 X 105 cells 
O157: 2 X 105 cells 
3 washes 
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